{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":56,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":56,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"ac4ca2444aff","filters":{"venue":"Drugs in R&D"}},"results":[{"id":"W2751648725","doi":"10.1007/s40268-017-0207-7","title":"Benzodiazepines and Z-Drugs: An Updated Review of Major Adverse Outcomes Reported on in Epidemiologic Research","year":2017,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":360,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Benzodiazepine; Adverse effect; Intensive care medicine; Dementia; Psychiatry; Harm; Disease; Pharmacology; Psychology; Internal medicine","authors":[{"name":"Jaden Brandt","is_ca":true},{"name":"Christine Leong","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.6375684566135268,"gpt":0.6246672980506429,"spread":0.01290115856288387,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00280213,0.00120876,0.002743607,0.008919439,0.0003253335,0.001349449,0.001191809,0.0009266143,0.003576886],"category_scores_gemma":[0.006688066,0.0005335156,0.002495243,0.01030813,0.0005861067,0.001646815,0.0009896095,0.001276529,0.0004616791],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001230758,"about_ca_system_score_gemma":0.003729005,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003945639,"about_ca_topic_score_gemma":0.00826671,"domain_scores_codex":[0.9981105,0.0003837846,0.0007810979,0.000205781,0.0004573959,0.00006143171],"domain_scores_gemma":[0.9938725,0.003738996,0.001354507,0.00009466229,0.000841303,0.00009801],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001536581,0.00005238201,0.001966124,0.270436,0.0015955,0.0002052948,0.0002543681,0.0002772062,0.0004205423,0.001534178,0.02509037,0.6980144],"study_design_scores_gemma":[0.00008656819,0.0002604861,0.01706264,0.2416035,0.00801697,0.003188091,0.0004984774,0.0001786392,0.0003944898,0.002027909,0.7265747,0.0001076617],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009357765,0.9994062,0.00003834158,0.0001711563,0.00009558916,0.000006467544,0.00005852021,0.000002920521,0.0001273151],"genre_scores_gemma":[0.0004718704,0.9990855,0.000131208,0.0001274439,0.00008119237,0.000006881773,0.00004784511,9.027162e-7,0.00004698543],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008919439,"threshold_uncertainty_score":0.01481926,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2556835195","doi":"10.1007/s40268-016-0153-9","title":"A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI","year":2016,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":342,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; McGill University","funders":"","keywords":"Sialorrhea; Salivary gland; Medicine; Oral medicine; Dentistry; Dermatology; Internal medicine; Surgery","authors":[{"name":"Ändy Wolff","is_ca":false},{"name":"Revan Kumar Joshi","is_ca":false},{"name":"Jørgen Ekström","is_ca":false},{"name":"Doron J. Aframian","is_ca":false},{"name":"Anne Marie Lynge Pedersen","is_ca":false},{"name":"Gordon Proctor","is_ca":false},{"name":"Nagamani Narayana","is_ca":false},{"name":"Alessandro Villa","is_ca":false},{"name":"Ying Wai Sia","is_ca":true},{"name":"Ardita Aliko","is_ca":false},{"name":"Richard McGowan","is_ca":false},{"name":"Alexander Ross Kerr","is_ca":false},{"name":"Siri Beier Jensen","is_ca":false},{"name":"Arjan Vissink","is_ca":false},{"name":"Colin Dawes","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0271903309366712,"gpt":0.3502844291157385,"spread":0.3230940981790673,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01256642,0.002206451,0.007974366,0.03424787,0.001106695,0.003385504,0.003304386,0.002257309,0.01904657],"category_scores_gemma":[0.03174714,0.001767815,0.00836009,0.02238846,0.0009577678,0.00545406,0.00269804,0.002030342,0.002235939],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006806758,"about_ca_system_score_gemma":0.02482766,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01237001,"about_ca_topic_score_gemma":0.03778947,"domain_scores_codex":[0.9915956,0.00254067,0.003934344,0.0005403178,0.001185883,0.0002032393],"domain_scores_gemma":[0.9804984,0.01074234,0.004549715,0.0003506952,0.003465323,0.0003936006],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001617032,0.00003504702,0.0008836701,0.869395,0.002062509,0.0001706008,0.0003465257,0.0002059072,0.000420615,0.0009583914,0.04097242,0.0843876],"study_design_scores_gemma":[0.0003207175,0.0001381028,0.003156615,0.8790354,0.006717363,0.0004599869,0.0003393475,0.0002346351,0.000132072,0.001265406,0.1081335,0.00006698645],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007095087,0.9695866,0.002243973,0.00534868,0.001149325,0.01118102,0.008098301,0.0001597282,0.001522994],"genre_scores_gemma":[0.004725689,0.9405198,0.01937954,0.005895177,0.0004116719,0.02143681,0.00492217,0.00004580659,0.002663394],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.03424787,"threshold_uncertainty_score":0.06645834,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2011049230","doi":"10.2165/00126839-200809050-00002","title":"Applications of Metabolomics in Drug Discovery and Development","year":2008,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":241,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Genome Alberta","keywords":"Metabolomics; Drug discovery; Drug development; Identification (biology); Biomarker discovery; Pharmaceutical industry; Data science; Computational biology; Drug; Computer science; Biochemical engineering; Medicine; Pharmacology; Bioinformatics; Biology; Proteomics; Engineering","authors":[{"name":"David S. Wishart","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01503816838159423,"gpt":0.2875014690859529,"spread":0.2724633007043586,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001476448,0.001547359,0.002474878,0.00302,0.0003685225,0.001444708,0.00154003,0.001905649,0.00332596],"category_scores_gemma":[0.001224341,0.0004927375,0.0007666781,0.003999115,0.001296391,0.002081732,0.001071003,0.002374461,0.003310038],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001093356,"about_ca_system_score_gemma":0.0009612807,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001139803,"about_ca_topic_score_gemma":0.002166875,"domain_scores_codex":[0.9996132,0.00007454617,0.00002640202,0.00006687713,0.0001932603,0.00002568489],"domain_scores_gemma":[0.9989786,0.0006408542,0.00007609907,0.00004257676,0.0002021835,0.00005971547],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008234518,0.00009205948,0.0002216169,0.005691906,0.0001501175,0.0002386289,0.00003567412,0.0008662311,0.005010506,0.009043771,0.02775235,0.9508148],"study_design_scores_gemma":[0.00003568318,0.000133174,0.001074015,0.001283056,0.0001294129,0.001387692,0.00006371841,0.0005879828,0.002685408,0.01221142,0.980352,0.0000564796],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001433207,0.9945304,0.002189332,0.0006711155,0.0004125068,0.00000943979,0.00002548953,0.00002762317,0.001990776],"genre_scores_gemma":[0.0009767977,0.9950722,0.001889204,0.0004480291,0.0005707415,0.0000114412,0.00003332524,0.000003533955,0.0009946916],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00332596,"threshold_uncertainty_score":0.01112646,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W8127528","doi":"10.2165/00126839-200708060-00003","title":"Improving Early Drug Discovery through ADME Modelling","year":2007,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":133,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"ADME; Drug development; Drug discovery; Drug; Risk analysis (engineering); Computer science; Pharmacology; Biochemical engineering; Medicine; Intensive care medicine; Bioinformatics; Engineering; Biology","authors":[{"name":"David S. Wishart","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08703858291226216,"gpt":0.3781868798061028,"spread":0.2911482968938407,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001534593,0.001369062,0.00236904,0.001187984,0.0002078726,0.0007712848,0.002084325,0.00106319,0.002630339],"category_scores_gemma":[0.002357708,0.0004978931,0.001078935,0.001507348,0.00046436,0.001279437,0.0007731019,0.001927189,0.001719461],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005457191,"about_ca_system_score_gemma":0.0006221158,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006507948,"about_ca_topic_score_gemma":0.0006787663,"domain_scores_codex":[0.9994469,0.0001489035,0.00003268649,0.00007343416,0.0002723216,0.00002572153],"domain_scores_gemma":[0.9987125,0.0008787114,0.00008744192,0.0001080698,0.0001864755,0.00002683009],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.0001491435,0.0001736335,0.0002542008,0.002990072,0.0002398131,0.0001121931,0.00001346854,0.054655,0.004374952,0.01813976,0.01224793,0.9066499],"study_design_scores_gemma":[0.0002876844,0.000832286,0.0007731435,0.001486945,0.0007881309,0.001909893,0.00002566797,0.3912247,0.05550395,0.08112562,0.4659106,0.0001313375],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"methods","genre_gemma":"review","genre_scores_codex":[0.005326637,0.415765,0.5584457,0.002621465,0.001170152,0.0001394547,0.0004748977,0.00202148,0.01403512],"genre_scores_gemma":[0.07187828,0.6058687,0.3062433,0.001386861,0.0009520876,0.0002041245,0.001167085,0.0002380901,0.01206163],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.002630339,"threshold_uncertainty_score":0.008799434,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2051962629","doi":"10.1007/s40268-015-0082-z","title":"mTOR: A Potential Therapeutic Target in Osteoarthritis?","year":2015,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":89,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Toronto Western Hospital; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"PI3K/AKT/mTOR pathway; Osteoarthritis; Cartilage; Medicine; Cancer research; Inflammation; Cell biology; Bioinformatics; Internal medicine; Pathology; Signal transduction; Biology; Anatomy","authors":[{"name":"Bandna Pal","is_ca":true},{"name":"Helal Endisha","is_ca":true},{"name":"Yue Zhang","is_ca":true},{"name":"Mohit Kapoor","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02481238498216827,"gpt":0.3256945292484221,"spread":0.3008821442662538,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002901122,0.000654435,0.001221335,0.001445997,0.000297894,0.0009291269,0.0007189096,0.001140615,0.004041274],"category_scores_gemma":[0.0003170826,0.0002019497,0.0003859641,0.001406471,0.000450671,0.001172091,0.0006520213,0.001986576,0.00298771],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004546584,"about_ca_system_score_gemma":0.0006506361,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006088414,"about_ca_topic_score_gemma":0.00145212,"domain_scores_codex":[0.9998924,0.00001716634,0.00001556075,0.00002161029,0.00003780359,0.00001549972],"domain_scores_gemma":[0.9999154,0.00002710191,0.00001382192,0.000002838354,0.00002620203,0.00001467473],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001306408,0.00008126537,0.0001305348,0.01097571,0.00008625964,0.0003237445,0.00006124932,0.0002575935,0.004023277,0.005818585,0.04129612,0.9368149],"study_design_scores_gemma":[0.00002702341,0.0001199399,0.0004275344,0.001391227,0.00007954023,0.001337403,0.0000446784,0.00008632298,0.0007001781,0.00215658,0.9936133,0.00001635396],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001650288,0.9978241,0.0001074996,0.0005205812,0.000216092,0.000004928873,0.00002265159,0.000009611856,0.001129623],"genre_scores_gemma":[0.0009107252,0.997593,0.0001672482,0.0002935015,0.0001662097,0.000007614221,0.00003657385,0.000001847311,0.0008232767],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004041274,"threshold_uncertainty_score":0.01351947,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W139570440","doi":"10.2165/00126839-200607020-00001","title":"Selective Phosphodiesterase (PDE)-4 Inhibitors","year":2006,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Neuroinflammation; Neuroprotection; Phosphodiesterase; Neuroscience; Disease; Medicine; Amyloid (mycology); Cyclic adenosine monophosphate; Microglia; Pharmacology; Alzheimer's disease; Psychology; Internal medicine; Biology; Enzyme; Inflammation; Biochemistry; Pathology; Receptor","authors":[{"name":"Afshin Ghavami","is_ca":true},{"name":"Warren D. Hirst","is_ca":true},{"name":"Thomas J. Novak","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01316560028924786,"gpt":0.293421831570008,"spread":0.2802562312807602,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003403818,0.001317881,0.00150135,0.001141728,0.0002474767,0.0006021319,0.0009820987,0.000697934,0.00346218],"category_scores_gemma":[0.0003349897,0.0002567843,0.0003894999,0.001055371,0.0004387119,0.000626541,0.0004546309,0.001859373,0.003087327],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006073904,"about_ca_system_score_gemma":0.0005922102,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009343739,"about_ca_topic_score_gemma":0.002910697,"domain_scores_codex":[0.9998882,0.0000121438,0.00001013235,0.00002431016,0.0000467849,0.00001832057],"domain_scores_gemma":[0.9999044,0.00003628285,0.00001748649,0.000004526824,0.00002132481,0.00001590013],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001793897,0.0001731515,0.0001214544,0.002831281,0.00007113364,0.0002785316,0.00002238311,0.0003871371,0.006073082,0.003107658,0.04745207,0.9393028],"study_design_scores_gemma":[0.0001342731,0.0002198645,0.0008419719,0.0005225898,0.0001197122,0.001648975,0.0000235595,0.0002027087,0.003964901,0.001425091,0.9908748,0.0000215433],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009266026,0.9907284,0.001567755,0.0006433896,0.0007201994,0.00002837417,0.00009554163,0.00007269948,0.005217128],"genre_scores_gemma":[0.004739561,0.9839795,0.00170146,0.0008344972,0.0003385794,0.00004791591,0.0002240316,0.00001032226,0.008124238],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00346218,"threshold_uncertainty_score":0.01158208,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2072492830","doi":"10.2165/00126839-200809030-00001","title":"A Review of the Role of CpG Oligodeoxynucleotides as Toll-Like Receptor 9 Agonists in Prophylactic and Therapeutic Vaccine Development in Infectious Diseases","year":2008,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":58,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; CpG Oligodeoxynucleotide; Toll-like receptor; Immunology; DNA vaccination; Pharmacology; Immune system; Biology; Innate immune system; Immunization; Gene; Genetics","authors":[{"name":"Kaveri Gupta","is_ca":true},{"name":"Curtis Cooper","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008426552575936072,"gpt":0.2615718066041785,"spread":0.2531452540282425,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005544315,0.0009383463,0.001671662,0.002132938,0.0002268649,0.0007730426,0.001015657,0.0009386064,0.003783401],"category_scores_gemma":[0.00059647,0.0003129758,0.0004194037,0.00243348,0.0003044344,0.001234912,0.000484655,0.001404179,0.002516568],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004779698,"about_ca_system_score_gemma":0.0008314573,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008581268,"about_ca_topic_score_gemma":0.002087155,"domain_scores_codex":[0.9998394,0.0000258348,0.00003057847,0.00002465647,0.00006465478,0.00001484683],"domain_scores_gemma":[0.9997312,0.0001100449,0.00004799571,0.000006482431,0.00007512502,0.00002905684],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001593242,0.00009391133,0.00009019968,0.01847857,0.00008903072,0.0002878391,0.00003422109,0.0002826812,0.004672958,0.001493683,0.05728577,0.9170318],"study_design_scores_gemma":[0.00003912356,0.0001544284,0.0004855824,0.002117386,0.0001160187,0.00119662,0.00002706172,0.0000858733,0.0008970019,0.0005968311,0.9942648,0.00001927966],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001189343,0.9983039,0.0001867367,0.0001547991,0.0004632168,0.000007283348,0.00002529331,0.000007896746,0.0007319588],"genre_scores_gemma":[0.0004664074,0.9976683,0.0003459985,0.0002642727,0.0003126611,0.000008395606,0.00004664236,0.000001769435,0.0008854293],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003783401,"threshold_uncertainty_score":0.01265675,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2117988243","doi":"10.2165/11593390-000000000-00000","title":"Impact of Intravenous Naltrexone on Intravenous Morphine-Induced High, Drug Liking, and Euphoric Effects in Experienced, Nondependent Male Opioid Users","year":2011,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Celerion (Canada)","funders":"Shionogi; Astellas Pharma; Purdue University; Eisai; Bayer HealthCare; Boston Scientific Corporation; Purdue Pharma; Gilead Sciences; GlaxoSmithKline; Nevro; Teva Pharmaceutical Industries; AstraZeneca; Pfizer","keywords":"Euphoriant; Naltrexone; Morphine; Medicine; Heroin; Opioid; Anesthesia; Narcotic antagonist; Visual analogue scale; Pharmacology; Drug; Internal medicine; Psychiatry","authors":[{"name":"Lynn R. Webster","is_ca":false},{"name":"Franklin K. Johnson","is_ca":false},{"name":"Joseph Stauffer","is_ca":false},{"name":"Beatrice Setnik","is_ca":false},{"name":"Sabrina Ciric","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0124207090589173,"gpt":0.2684139299841857,"spread":0.2559932209252684,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005530039,0.0002542439,0.0003466487,0.0001130234,0.0001243959,0.0002546641,0.0001961825,0.0002518196,0.001829649],"category_scores_gemma":[0.002064166,0.0001692769,0.0003476377,0.00008427685,0.0002709228,0.0002488984,0.0001789129,0.0004189968,0.0001229082],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000184258,"about_ca_system_score_gemma":0.0001774412,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003249445,"about_ca_topic_score_gemma":0.0006510464,"domain_scores_codex":[0.9995373,0.0002449206,0.00004326422,0.00004521425,0.00008218708,0.00004701803],"domain_scores_gemma":[0.9990517,0.0003851791,0.0002460529,0.00004798844,0.0000418787,0.0002271424],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4521723,0.08992577,0.1181068,0.001234018,0.00125906,0.0005012296,0.0005786,0.001536153,0.1810459,0.000122012,0.0003507559,0.1531674],"study_design_scores_gemma":[0.01372464,0.6624467,0.3084748,0.00003432741,0.0003222842,0.0003884639,0.0001955233,0.00133336,0.01259234,0.00003577211,0.000425487,0.00002634804],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9997205,0.00006499606,0.0000219503,0.000005926986,0.000003031709,0.00003471177,0.00002214108,0.000002250785,0.0001245098],"genre_scores_gemma":[0.999518,0.00008409788,0.0001378998,0.00002891852,0.000009224553,0.00003478107,0.00004391539,0.000001142431,0.0001420001],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001829649,"threshold_uncertainty_score":0.006120801,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3173963108","doi":"10.1007/s40268-021-00351-6","title":"Potential for the Repurposing of Adamantane Antivirals for COVID-19","year":2021,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Amantadine; Memantine; Coronavirus; Rimantadine; Virology; Drug repositioning; Pharmacology; Viral replication; Biology; Virus; Receptor; Medicine; NMDA receptor; Influenza A virus; Drug; Biochemistry; Coronavirus disease 2019 (COVID-19); Disease","authors":[{"name":"Roger F. Butterworth","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1160359683892616,"gpt":0.4612790641218202,"spread":0.3452430957325585,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003558304,0.0004584626,0.0003571194,0.000438109,0.0002216553,0.0005879287,0.0003992439,0.0005820839,0.007790541],"category_scores_gemma":[0.0002355179,0.0001693274,0.0007661792,0.0001948542,0.0001937582,0.0005731734,0.0003685099,0.0008438581,0.001782725],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00027092,"about_ca_system_score_gemma":0.0002920021,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003792587,"about_ca_topic_score_gemma":0.00071644,"domain_scores_codex":[0.9998635,0.00003598495,0.000009002211,0.00002215836,0.00003490357,0.00003438732],"domain_scores_gemma":[0.9999067,0.00001307513,0.00002037013,0.000009989414,0.00002676306,0.00002302794],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009145845,0.0007533361,0.001012213,0.001771065,0.0001283452,0.001361878,0.0001320178,0.001572682,0.8104765,0.006015487,0.006166929,0.169695],"study_design_scores_gemma":[0.0004732597,0.008698209,0.003881094,0.0003375406,0.0002117361,0.003914364,0.0001549628,0.003660281,0.5479613,0.003705452,0.4269376,0.00006423114],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.4797324,0.4106524,0.03581987,0.005203453,0.002019699,0.0009338455,0.00211423,0.0005892864,0.06293494],"genre_scores_gemma":[0.8133047,0.1256437,0.01915918,0.001960318,0.0004096006,0.0002496723,0.002077476,0.00007833073,0.03711694],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.007790541,"threshold_uncertainty_score":0.02606195,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2603821422","doi":"10.1007/s40268-017-0180-1","title":"Revisiting CDK Inhibitors for Treatment of Glioblastoma Multiforme","year":2017,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Windsor","funders":"Canadian Cancer Society Research Institute","keywords":"Cyclin-dependent kinase; Glioma; Glioblastoma; Repurposing; Disease; Medicine; Population; Biology; Bioinformatics; Cancer research; Cancer; Cell cycle; Internal medicine","authors":[{"name":"Dorota Lubanska","is_ca":true},{"name":"Lisa A. Porter","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08373018955416103,"gpt":0.4042266653883339,"spread":0.3204964758341728,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005462564,0.0006741741,0.001085026,0.00202906,0.0002487188,0.0008476541,0.0008735978,0.0007799307,0.002958937],"category_scores_gemma":[0.0005006178,0.0002975335,0.0006290016,0.001325263,0.0004020638,0.001358249,0.0005645289,0.00217804,0.001598341],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005804274,"about_ca_system_score_gemma":0.0007970527,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00105205,"about_ca_topic_score_gemma":0.003514206,"domain_scores_codex":[0.9998329,0.00003116401,0.00002891582,0.00002862695,0.00005943238,0.00001888088],"domain_scores_gemma":[0.9998285,0.0000828163,0.0000276466,0.000004506946,0.00004274824,0.0000137353],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009609263,0.00009164423,0.0001345458,0.01394907,0.0001046663,0.0002888356,0.00007317952,0.0004339439,0.002202346,0.004000289,0.02349228,0.9551331],"study_design_scores_gemma":[0.00004558642,0.0001539236,0.0005477588,0.002788774,0.0001193468,0.001215169,0.00004993171,0.0001548132,0.0007743298,0.001875427,0.9922602,0.00001468398],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002292898,0.9979868,0.0001031379,0.0003288923,0.0001746655,0.000007380039,0.00002101832,0.000007990629,0.001140761],"genre_scores_gemma":[0.001063579,0.9977552,0.0001701022,0.0002824231,0.0001097751,0.00000743404,0.00003543357,0.000001843651,0.0005741185],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002958937,"threshold_uncertainty_score":0.009898603,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2024058161","doi":"10.2165/11537800-000000000-00000","title":"MicroRNA: Potential Targets for the Development of Novel Drugs?","year":2010,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"microRNA; Biology; Epigenetics; Regulation of gene expression; Gene regulatory network; Gene expression; Translation (biology); Gene silencing; Computational biology; Gene; Messenger RNA; Cell biology; Cancer research; Genetics","authors":[{"name":"Wei Wu","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01959533176365454,"gpt":0.3033970508526896,"spread":0.2838017190890351,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000828415,0.0009956757,0.001818607,0.001060002,0.0003257437,0.001267959,0.001022307,0.002277682,0.0064257],"category_scores_gemma":[0.0006268182,0.0003516409,0.0004465531,0.0008928828,0.0009889939,0.002673517,0.0007263816,0.002499599,0.006813218],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007324049,"about_ca_system_score_gemma":0.0006542179,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002972296,"about_ca_topic_score_gemma":0.0006532678,"domain_scores_codex":[0.9997731,0.00006154284,0.00002122728,0.00004504254,0.00007406505,0.00002507487],"domain_scores_gemma":[0.9998264,0.00006253357,0.00002390139,0.0000122904,0.00004290539,0.00003199091],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001962719,0.0001503392,0.0002099907,0.004782517,0.00007470629,0.0007017702,0.0001118322,0.0004375634,0.01306481,0.02338398,0.07136838,0.8855178],"study_design_scores_gemma":[0.00004673363,0.0001147865,0.0002057251,0.0005816378,0.00003199412,0.001407227,0.00004916985,0.000161929,0.001199775,0.00694069,0.9892418,0.00001855301],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002883596,0.9908367,0.001022674,0.003105471,0.001135322,0.00001509951,0.00003141764,0.00002948283,0.003535399],"genre_scores_gemma":[0.00291831,0.9873964,0.001784769,0.002261029,0.001153147,0.00004323742,0.0000682986,0.000009341131,0.004365485],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0064257,"threshold_uncertainty_score":0.02149612,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2898934370","doi":"10.1007/s40268-018-0253-9","title":"Efficacy and Safety of Budesonide in the Treatment of Eosinophilic Esophagitis: Updated Systematic Review and Meta-Analysis of Randomized and Non-Randomized Studies","year":2018,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Cancer Institute","keywords":"Randomized controlled trial; Medicine; Budesonide; Internal medicine; Meta-analysis; Eosinophilic esophagitis; Cochrane Library; Placebo; Confidence interval; Relative risk; Adverse effect; Gastroenterology; Asthma; Pathology; Disease","authors":[{"name":"Prashanth Rawla","is_ca":false},{"name":"Tagore Sunkara","is_ca":false},{"name":"Krishna Chaitanya Thandra","is_ca":false},{"name":"Vinaya Gaduputi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06042388775615146,"gpt":0.3792141270448372,"spread":0.3187902392886857,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02522507,0.003028569,0.02437038,0.00980965,0.000649792,0.003742461,0.002671797,0.002781447,0.003547362],"category_scores_gemma":[0.05295248,0.00193408,0.0419418,0.008389032,0.0008404704,0.002416306,0.001809063,0.00221438,0.000291623],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003501202,"about_ca_system_score_gemma":0.006148806,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006482229,"about_ca_topic_score_gemma":0.01251057,"domain_scores_codex":[0.9798185,0.008211139,0.007363882,0.001464039,0.002675783,0.0004667444],"domain_scores_gemma":[0.9721056,0.01724064,0.006203236,0.0008527054,0.003263068,0.0003347547],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001539419,0.00003474091,0.002490537,0.4947985,0.4854455,0.0001182934,0.00007916559,0.0003561095,0.000202503,0.0001212325,0.0005793248,0.01423467],"study_design_scores_gemma":[0.0005907189,0.0001745715,0.002088029,0.03450728,0.9608275,0.00008764332,0.00003274636,0.0001091801,0.0001048434,0.0001267032,0.001329265,0.00002154112],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002456499,0.9958072,0.0004243378,0.0002118491,0.0001657389,0.000343545,0.0004002581,0.00001887177,0.0001716992],"genre_scores_gemma":[0.08424626,0.9090614,0.002790264,0.001086005,0.0003096831,0.001334071,0.0009100704,0.00002960945,0.0002326691],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02522507,"threshold_uncertainty_score":0.1334044,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3085493311","doi":"10.1007/s40268-020-00322-3","title":"Nimodipine Pharmacokinetic Variability in Various Patient Populations","year":2020,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Intracranial Aneurysms: Treatment and Complications","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Nimodipine; Medicine; Pharmacokinetics; Subarachnoid hemorrhage; Dosing; Anesthesia; MEDLINE; Clinical significance; Intensive care medicine; Pharmacology; Internal medicine","authors":[{"name":"Sherif Hanafy Mahmoud","is_ca":true},{"name":"Xinqi Ji","is_ca":true},{"name":"Fadumo Ahmed Isse","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04794077184678272,"gpt":0.3501292232052786,"spread":0.3021884513584959,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003891659,0.000524206,0.002820116,0.00478822,0.0002770152,0.00134913,0.0007548458,0.0009194967,0.001369435],"category_scores_gemma":[0.01900785,0.0003113312,0.002631016,0.005921268,0.0004170919,0.0009911564,0.0005734483,0.0005758486,0.0001287403],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001136199,"about_ca_system_score_gemma":0.003017541,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00295096,"about_ca_topic_score_gemma":0.004773335,"domain_scores_codex":[0.9954407,0.001284732,0.001973232,0.00048086,0.0007411626,0.00007928824],"domain_scores_gemma":[0.9825957,0.01370302,0.002881641,0.0001856804,0.0005866168,0.0000474093],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005587011,0.00005340376,0.0115951,0.6320673,0.007923556,0.0009174252,0.0007447933,0.0004076294,0.001017038,0.001227319,0.003991627,0.339496],"study_design_scores_gemma":[0.000495667,0.0009960182,0.09316777,0.6413552,0.07724422,0.01224769,0.002195392,0.0006252337,0.002272815,0.003772969,0.1653841,0.0002429254],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002370815,0.9964474,0.0001702107,0.0002551566,0.00003763256,0.00004266443,0.0003215313,0.00000380269,0.0003507198],"genre_scores_gemma":[0.03317088,0.9647352,0.0007206785,0.0006437326,0.0001219311,0.0001473564,0.0003700543,0.000004991163,0.00008515827],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00478822,"threshold_uncertainty_score":0.02058131,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3156032412","doi":"10.1007/s40268-021-00345-4","title":"Ammonia Removal by Metabolic Scavengers for the Prevention and Treatment of Hepatic Encephalopathy in Cirrhosis","year":2021,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Hyperammonemia; Urea cycle; Hepatic encephalopathy; Lactulose; Cirrhosis; Internal medicine; Ornithine; Chemistry; Phenylbutyrate; Medicine; Endocrinology; Biochemistry; Pharmacology; Arginine; Amino acid","authors":[{"name":"Roger F. Butterworth","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03239207941204482,"gpt":0.3379310956392957,"spread":0.3055390162272509,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000736776,0.0006491418,0.002024839,0.002417069,0.0001761104,0.0007060129,0.0008130419,0.001037431,0.004705356],"category_scores_gemma":[0.001587131,0.0002355224,0.001921722,0.002086569,0.0002346856,0.0006616546,0.0004303977,0.0008657872,0.0006475853],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005058829,"about_ca_system_score_gemma":0.0009383775,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001483997,"about_ca_topic_score_gemma":0.003165964,"domain_scores_codex":[0.9997451,0.00007346111,0.00006389988,0.000031206,0.00006565102,0.00002065183],"domain_scores_gemma":[0.9993891,0.0003702058,0.0001299872,0.00001138609,0.00007913866,0.00002026012],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003842651,0.00009443812,0.0002496536,0.2446329,0.001723055,0.0001340739,0.00005661795,0.0002604321,0.0008140336,0.0009337567,0.0121689,0.738548],"study_design_scores_gemma":[0.0008124203,0.0009104387,0.008113813,0.2214565,0.01826809,0.003072974,0.0002372232,0.0004549566,0.001859984,0.00255167,0.7421724,0.00008950505],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001184498,0.9996091,0.00001902084,0.00005504751,0.00003324074,0.000004861106,0.00001437482,0.000002353712,0.0001436016],"genre_scores_gemma":[0.001147386,0.9985546,0.00006891468,0.00007470231,0.00003119435,0.000007681733,0.00002443173,6.999125e-7,0.00009034893],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004705356,"threshold_uncertainty_score":0.01574105,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4319332896","doi":"10.1007/s40268-023-00413-x","title":"Risk of Adverse Events Associated with Domperidone and Metoclopramide in Gastroparesis: Systematic Review and Meta-analysis","year":2023,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"Takeda Pharmaceuticals U.S.A.","keywords":"Domperidone; Medicine; Gastroparesis; Metoclopramide; Meta-analysis; Internal medicine; Adverse effect; Odds ratio; Placebo; Extrapyramidal symptoms; Confidence interval; Antipsychotic; Gastric emptying; Schizophrenia (object-oriented programming); Dopamine; Psychiatry; Pathology","authors":[{"name":"Daniela R. Junqueira","is_ca":true},{"name":"Dimitri Bennett","is_ca":false},{"name":"Susanna Y. Huh","is_ca":false},{"name":"Kyle Fahrbach","is_ca":false},{"name":"Binod Neupane","is_ca":true},{"name":"Marissa Betts","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05812192699939572,"gpt":0.3338852237016718,"spread":0.2757632967022761,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01447268,0.002888605,0.01751797,0.007630346,0.0005406906,0.002780974,0.002084032,0.002222476,0.003043237],"category_scores_gemma":[0.03407128,0.001667708,0.04634194,0.007947241,0.0006811331,0.001486222,0.001606921,0.001984077,0.0002690461],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002306793,"about_ca_system_score_gemma":0.0030427,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005252135,"about_ca_topic_score_gemma":0.01056494,"domain_scores_codex":[0.9884508,0.005473576,0.003489187,0.001058784,0.001244254,0.0002834854],"domain_scores_gemma":[0.9747238,0.01842274,0.004426349,0.0005879647,0.001565043,0.0002741162],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001384284,0.00002142007,0.003948616,0.3283184,0.6576408,0.0001119455,0.00005727587,0.0004537952,0.0001375003,0.00009113377,0.0003675897,0.007467319],"study_design_scores_gemma":[0.000344878,0.0001387662,0.00283354,0.01738833,0.9779128,0.0001001238,0.00002807753,0.0001625713,0.00007351134,0.0001151424,0.0008859712,0.00001629772],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004049079,0.9943166,0.0005092558,0.0001563322,0.0001140141,0.0002209485,0.0004314215,0.00002042248,0.0001819378],"genre_scores_gemma":[0.1756183,0.818427,0.002535615,0.0008195839,0.00030219,0.001174044,0.000801725,0.00003294134,0.0002886781],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01751797,"threshold_uncertainty_score":0.07653975,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2736936940","doi":"10.1007/s40268-017-0195-7","title":"Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region","year":2017,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"CYP2C19; CYP2C9; Pharmacogenomics; Genotyping; Phenytoin; Genotype; Medicine; Pharmacogenetics; Pharmacokinetics; Allele; Middle East; Genetics; Pharmacology; Epilepsy; Biology; Geography; Gene; Psychiatry","authors":[{"name":"Renée Dagenais","is_ca":true},{"name":"Kyle John Wilby","is_ca":false},{"name":"Hazem Elewa","is_ca":false},{"name":"Mary H. H. Ensom","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.4897565503539779,"gpt":0.5137854583330572,"spread":0.02402890797907936,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00390885,0.0005205736,0.002637113,0.003018284,0.0002966891,0.001178482,0.0007040684,0.0007863715,0.001445536],"category_scores_gemma":[0.01936819,0.0003005711,0.002943703,0.004226535,0.0003880259,0.0008395051,0.0005592747,0.000439889,0.00007072602],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009196242,"about_ca_system_score_gemma":0.002540964,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008172783,"about_ca_topic_score_gemma":0.01497011,"domain_scores_codex":[0.9961489,0.001549174,0.001273618,0.000376662,0.000486683,0.0001650069],"domain_scores_gemma":[0.9849508,0.01048259,0.003661763,0.0001669045,0.0006294876,0.0001085192],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001804477,0.00005930504,0.1001744,0.6995077,0.0681951,0.001239007,0.001066436,0.0006007603,0.001105688,0.0007125008,0.002416348,0.1231183],"study_design_scores_gemma":[0.0008531947,0.0006030716,0.3070052,0.4356523,0.223253,0.003522148,0.001615959,0.0003603901,0.0009221361,0.001059802,0.02505385,0.00009885964],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02408425,0.9743858,0.00009136638,0.0004436512,0.00004493166,0.00005128201,0.0004483103,0.000002347827,0.0004480907],"genre_scores_gemma":[0.3707122,0.6268476,0.0006994553,0.0007886125,0.0001117986,0.0001906321,0.0005386274,0.000004646432,0.0001064581],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008172783,"threshold_uncertainty_score":0.02067226,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2919757880","doi":"10.1007/s40268-019-0263-2","title":"Ulcerative Colitis: Shifting Sands","year":2019,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Pfizer","keywords":"Medicine; Ulcerative colitis; Disease; Inflammatory bowel disease; Quality of life (healthcare); Proctitis; Internal medicine; Colitis; Intensive care medicine; Gastroenterology","authors":[{"name":"Geert D’Haens","is_ca":false},{"name":"James O. Lindsay","is_ca":false},{"name":"Remo Panaccione","is_ca":true},{"name":"Stefan Schreiber","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02149741843679606,"gpt":0.3160678775912923,"spread":0.2945704591544963,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005130253,0.0008516942,0.001343074,0.002194349,0.0004363115,0.001641131,0.0007150252,0.001470528,0.004838475],"category_scores_gemma":[0.001132345,0.0002309379,0.0005508003,0.001633877,0.0008519158,0.002217938,0.0009245388,0.002512464,0.003505264],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008703724,"about_ca_system_score_gemma":0.001098412,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001420549,"about_ca_topic_score_gemma":0.002305466,"domain_scores_codex":[0.9996679,0.00006579695,0.00005726119,0.00006033665,0.0001182685,0.00003046207],"domain_scores_gemma":[0.9996154,0.0001677384,0.00005172609,0.00001580556,0.0001019245,0.00004735394],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00008042892,0.00002649445,0.000192103,0.00846201,0.00006184869,0.0002702738,0.00008421389,0.0001784984,0.0004034997,0.006364075,0.1153887,0.868488],"study_design_scores_gemma":[0.00001074532,0.00003033658,0.0004743652,0.00372196,0.00003605934,0.001670063,0.00006303505,0.00002692185,0.0000721496,0.002403334,0.9914802,0.00001094978],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009375864,0.9945809,0.00009794151,0.001502741,0.001269017,0.000003936607,0.0000189751,0.00001290595,0.00241987],"genre_scores_gemma":[0.0008732241,0.9939084,0.000146679,0.001623571,0.001251892,0.000005895507,0.00003748691,0.000003965964,0.002148881],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004838475,"threshold_uncertainty_score":0.0161863,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1976165878","doi":"10.2165/11593140-000000000-00000","title":"Impact of Respiratory Syncytial Virus","year":2011,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Respiratory viral infections research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; Jewish General Hospital; Children's Hospital of Winnipeg; Mount Sinai Hospital","funders":"","keywords":"Palivizumab; Medicine; Transmission (telecommunications); Respiratory tract infections; Virus; Intensive care medicine; Disease; Infection control; Pediatrics; Health care; Respiratory system; Immunology; Internal medicine","authors":[{"name":"Marianne Bracht","is_ca":true},{"name":"Debbie Basevitz","is_ca":true},{"name":"Marilyn Cranis","is_ca":true},{"name":"Rose Paulley","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1664323907710402,"gpt":0.4867733928526308,"spread":0.3203410020815906,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006857648,0.0007560836,0.001184866,0.0009480714,0.0001882634,0.0009296213,0.0006550543,0.0009484089,0.004749041],"category_scores_gemma":[0.00123814,0.0001987682,0.0007250949,0.0007452896,0.0002482848,0.0006436727,0.0005729535,0.000899821,0.001840411],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005152269,"about_ca_system_score_gemma":0.001030508,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001929688,"about_ca_topic_score_gemma":0.002297515,"domain_scores_codex":[0.9996032,0.0001008574,0.00005645054,0.00004661375,0.0001529207,0.0000399605],"domain_scores_gemma":[0.9994932,0.0002726651,0.00007265505,0.00001130702,0.000114145,0.00003597506],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000134128,0.00005902853,0.0009388456,0.02289772,0.0002937907,0.000540939,0.00009097629,0.0002605052,0.003025437,0.001763309,0.02514628,0.944849],"study_design_scores_gemma":[0.0000484898,0.0002585374,0.005652017,0.00870103,0.0004097538,0.003911482,0.0001302671,0.00007988908,0.00176061,0.0009036512,0.9781191,0.00002522407],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002823815,0.9975076,0.00003214904,0.0001781153,0.0001615379,0.000003912005,0.00002307839,0.000003126581,0.001808101],"genre_scores_gemma":[0.004744413,0.9938825,0.00009885716,0.0002387399,0.0001516007,0.000006820636,0.00006062273,0.000001399356,0.0008149675],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004749041,"threshold_uncertainty_score":0.01588708,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4283169331","doi":"10.1007/s40268-022-00391-6","title":"Analysis of the US Safety Data for Edaravone (Radicava®) From the Third Year After Launch","year":2022,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Adverse effect; Edaravone; Amyotrophic lateral sclerosis; Postmarketing surveillance; Clinical trial; Disease; Intensive care medicine; Internal medicine","authors":[{"name":"Angela Genge","is_ca":true},{"name":"Benjamin Rix Brooks","is_ca":false},{"name":"Björn Oskarsson","is_ca":false},{"name":"Alexander Kalin","is_ca":false},{"name":"Ming Ji","is_ca":false},{"name":"Stephen Apple","is_ca":false},{"name":"Laura Bower","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03374131150750272,"gpt":0.3130737246580986,"spread":0.2793324131505959,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006419301,0.000332674,0.0004788817,0.002458987,0.0003085733,0.0009585028,0.0004136886,0.0003820826,0.004086641],"category_scores_gemma":[0.01326209,0.0002144986,0.00163795,0.003727363,0.0002575043,0.0005249425,0.0005373133,0.000896944,0.001068287],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001567296,"about_ca_system_score_gemma":0.003363385,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005959238,"about_ca_topic_score_gemma":0.006080484,"domain_scores_codex":[0.9947723,0.0009192188,0.001102558,0.0005335509,0.00234958,0.0003227909],"domain_scores_gemma":[0.9701219,0.00578788,0.01505089,0.001177604,0.007302123,0.0005595801],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009683916,0.0003671471,0.7866771,0.002816094,0.002479119,0.0006105101,0.0003524169,0.002243656,0.003090901,0.0008523866,0.04600245,0.1448243],"study_design_scores_gemma":[0.0004297675,0.001900561,0.9113677,0.0008664735,0.001187284,0.001407899,0.0002508206,0.001845961,0.004262984,0.0004129571,0.07600419,0.00006348098],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7267733,0.02002548,0.004953446,0.002148149,0.000272528,0.001105895,0.2246949,0.0004881232,0.01953809],"genre_scores_gemma":[0.8469249,0.00621631,0.00199325,0.001657491,0.0002010258,0.0008350242,0.1388892,0.0001067249,0.003176107],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006419301,"threshold_uncertainty_score":0.0339489,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386046570","doi":"10.1007/s40268-023-00428-4","title":"Tremor Induced by Cyclosporine, Tacrolimus, Sirolimus, or Everolimus: A Review of the Literature","year":2023,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Oral and gingival health research","field":"Health Professions","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Tacrolimus; Everolimus; Sirolimus; Medicine; Calcineurin; Dosing; Therapeutic drug monitoring; Adverse effect; Pharmacology; Internal medicine; Ciclosporin; Transplantation; Drug","authors":[{"name":"Aparna Wagle Shukla","is_ca":false},{"name":"Caroline Lunny","is_ca":false},{"name":"Omar Mahboob","is_ca":false},{"name":"Uzair Khalid","is_ca":true},{"name":"Malea Joyce","is_ca":true},{"name":"Nivedita Jha","is_ca":false},{"name":"Nandakumar Nagaraja","is_ca":false},{"name":"Ashutosh M. Shukla","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2153648129055369,"gpt":0.5519977062624285,"spread":0.3366328933568916,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002165455,0.001261194,0.003661622,0.01353298,0.0005946641,0.001558258,0.00141077,0.001312916,0.002994848],"category_scores_gemma":[0.007732881,0.000642744,0.003325165,0.01344393,0.0005897768,0.001893065,0.000967733,0.0007093283,0.0004051788],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001519994,"about_ca_system_score_gemma":0.003939271,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003223468,"about_ca_topic_score_gemma":0.005954029,"domain_scores_codex":[0.9978006,0.0002951706,0.001239026,0.0002267734,0.0003624955,0.00007577485],"domain_scores_gemma":[0.9889421,0.00741114,0.002431646,0.0001278287,0.0009306273,0.000156553],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0002464466,0.00004313398,0.001653581,0.8174675,0.002212562,0.001211964,0.0003885436,0.0001547204,0.0006006105,0.0003572137,0.007219472,0.1684442],"study_design_scores_gemma":[0.0001698432,0.0004383685,0.01574401,0.7873402,0.0324338,0.01235787,0.0008652857,0.0001527822,0.0006770761,0.001026096,0.1486852,0.0001094317],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005796571,0.9988237,0.00004437188,0.0001339369,0.00008777819,0.00002516818,0.00009768253,0.000004086125,0.0002036659],"genre_scores_gemma":[0.003125737,0.9961447,0.0001317893,0.0002650866,0.0001257635,0.00003669639,0.00009769126,0.000001655055,0.00007091436],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01353298,"threshold_uncertainty_score":0.01145214,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2014795914","doi":"10.1007/s40268-013-0030-8","title":"An In Vitro Analysis of Disintegration Times of Different Formulations of Olanzapine Orodispersible Tablet: A Preliminary Report","year":2013,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Advanced Drug Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Eli Lilly (Canada); Waypoint Centre for Mental Health Care; University of Toronto","funders":"Eli Lilly and Company","keywords":"Olanzapine; Active ingredient; Dissolution; Excipient; Chromatography; Dosage form; Dissolution testing; Materials science; Pharmacology; Chemistry; Medicine; Biopharmaceutics Classification System; Schizophrenia (object-oriented programming)","authors":[{"name":"D.T. Hobbs","is_ca":false},{"name":"Jamie Karagianis","is_ca":true},{"name":"Tamás Treuer","is_ca":false},{"name":"Joel Raskin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04067849629454533,"gpt":0.3935812172620812,"spread":0.3529027209675358,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007083363,0.000531839,0.0004259019,0.0003987002,0.0002349073,0.0003078384,0.0002246184,0.00031572,0.001438357],"category_scores_gemma":[0.0006683038,0.0001769073,0.0006340052,0.0006254432,0.0001684658,0.0002643243,0.0001780021,0.0005033886,0.0003219073],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000359978,"about_ca_system_score_gemma":0.0003945649,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002482852,"about_ca_topic_score_gemma":0.003036616,"domain_scores_codex":[0.9994538,0.0001035439,0.000108704,0.00009349522,0.0001909579,0.0000494647],"domain_scores_gemma":[0.9993042,0.0002636687,0.0001447995,0.00004695589,0.000202813,0.00003750229],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00142938,0.0002343089,0.002112273,0.0003923546,0.00006879111,0.0001472428,0.0001669412,0.0002421473,0.9856176,0.00005486273,0.0001424431,0.009391755],"study_design_scores_gemma":[0.0001055526,0.01066525,0.03163463,0.00004377785,0.0003874056,0.0007371608,0.0001902456,0.002218429,0.949617,0.0000432432,0.00431818,0.00003916777],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9740669,0.01364701,0.006566356,0.0001059291,0.00009172133,0.0003246136,0.002178145,0.00005400722,0.002965379],"genre_scores_gemma":[0.9706907,0.005707628,0.01711089,0.00008675477,0.00004849383,0.0002014544,0.003191228,0.00003455967,0.00292826],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002482852,"threshold_uncertainty_score":0.004936755,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2802063352","doi":"10.1007/s40268-018-0232-1","title":"A Phase I Study of the Pharmacokinetics and Pharmacodynamics of Intranasal Doxylamine in Subjects with Chronic Intermittent Sleep Impairment","year":2018,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Obstructive Sleep Apnea Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Celerion (Canada)","funders":"GlaxoSmithKline","keywords":"Nasal administration; Cmax; Pharmacokinetics; Medicine; Pharmacodynamics; Pharmacology; Bioavailability; Nasal spray; Dosing; Area under the curve; Oral administration; Anesthesia","authors":[{"name":"Mark Allison","is_ca":true},{"name":"Cecilia Hale","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01161056248182597,"gpt":0.3292209934672916,"spread":0.3176104309854656,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001205439,0.00116124,0.001567454,0.0002726865,0.0004030769,0.0005595026,0.0006844697,0.0008522877,0.002733425],"category_scores_gemma":[0.0009463603,0.0005896133,0.0009735043,0.0002722826,0.0007264595,0.0004710343,0.0002713263,0.001871944,0.0005176411],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006511162,"about_ca_system_score_gemma":0.001553806,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001107075,"about_ca_topic_score_gemma":0.001951046,"domain_scores_codex":[0.9995883,0.0001676126,0.0000259662,0.00008815716,0.00004794855,0.00008207251],"domain_scores_gemma":[0.9991556,0.0001431699,0.0002068915,0.000100612,0.00009786067,0.0002957208],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6726339,0.132294,0.009236168,0.0009666487,0.001334629,0.0002192345,0.0004813854,0.001264995,0.0982519,0.0001474571,0.001525535,0.08164416],"study_design_scores_gemma":[0.2013386,0.7778667,0.01412796,0.0000184354,0.0003510926,0.000107862,0.00005090944,0.0006212692,0.004403373,0.00005121262,0.001044466,0.00001824336],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944572,0.000741692,0.0008082211,0.0001382132,0.00005849234,0.002922541,0.0003582214,0.00004263025,0.0004728171],"genre_scores_gemma":[0.9895504,0.0009230825,0.002437607,0.0004619721,0.0001263621,0.004079142,0.0007239994,0.00002185639,0.001675514],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002733425,"threshold_uncertainty_score":0.009144247,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2520135767","doi":"10.1007/s40268-016-0142-z","title":"Safety of Mebendazole Use During Lactation: A Case Series Report","year":2016,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Breastfeeding Practices and Influences","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"","keywords":"Mebendazole; Breastfeeding; Medicine; Adverse effect; Lactation; Irritability; Pediatrics; Obstetrics; Pregnancy; Internal medicine; Anxiety; Psychiatry; Biology","authors":[{"name":"Nour Karra","is_ca":false},{"name":"Rana Cohen","is_ca":false},{"name":"Maya Berlin","is_ca":false},{"name":"Natalie Dinavitser","is_ca":false},{"name":"Gideon Koren","is_ca":true},{"name":"Matitiahu Berkovitch","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02102129683009323,"gpt":0.2973752522973009,"spread":0.2763539554672076,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005693362,0.001668198,0.001354787,0.002203582,0.002643919,0.001493971,0.001202374,0.004361906,0.002440276],"category_scores_gemma":[0.004096856,0.0009507599,0.00141761,0.001389772,0.001902577,0.001564294,0.001655608,0.002650275,0.0009925781],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001299834,"about_ca_system_score_gemma":0.001175492,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001973833,"about_ca_topic_score_gemma":0.002017972,"domain_scores_codex":[0.998714,0.0002218771,0.0001881611,0.0002882338,0.0002543174,0.0003334768],"domain_scores_gemma":[0.996344,0.001050338,0.001316734,0.0003411957,0.000188036,0.0007597295],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.00005580477,0.0001042979,0.02580975,0.00004101133,0.00002061874,0.9707647,0.0003587866,0.00003790751,0.0006188385,0.00008523766,0.0002396546,0.001863434],"study_design_scores_gemma":[0.00000896814,0.0001169334,0.006910959,0.00001759722,0.00001990398,0.9917579,0.0002640597,0.000106678,0.0002681454,0.00005862749,0.0004590521,0.00001107915],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9806247,0.008791742,0.001988551,0.002413681,0.0002966405,0.0001115015,0.0001348918,0.00009349977,0.005544657],"genre_scores_gemma":[0.9955601,0.00190816,0.000454796,0.0006088574,0.000513097,0.00002602873,0.00005893273,0.00001362974,0.0008563646],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004361906,"threshold_uncertainty_score":0.009430945,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1983697728","doi":"10.2165/11596340-000000000-00000","title":"Boosted Tipranavir versus Darunavir in Treatment-Experienced Patients","year":2011,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Boehringer Ingelheim","keywords":"Darunavir; Raltegravir; Ritonavir; Medicine; Maraviroc; Viral load; Regimen; Adverse effect; Internal medicine; Integrase inhibitor; Clinical endpoint; Gastroenterology; Virology; Pharmacology; Randomized controlled trial; Human immunodeficiency virus (HIV); Antiretroviral therapy","authors":[{"name":"Mabrouk Elgadi","is_ca":true},{"name":"Peter J. Piliero","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04272275973899473,"gpt":0.290875164831624,"spread":0.2481524050926293,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001164909,0.0003677427,0.001243213,0.0001380974,0.0001676019,0.0007563781,0.0003542632,0.0005181872,0.003613671],"category_scores_gemma":[0.001281711,0.0002132477,0.0008480263,0.0001951428,0.000325905,0.0004213242,0.0002152464,0.001362951,0.0003398113],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002900386,"about_ca_system_score_gemma":0.000521871,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002303077,"about_ca_topic_score_gemma":0.0007651002,"domain_scores_codex":[0.9996257,0.0002145156,0.00003371518,0.00004958075,0.00002288345,0.00005361643],"domain_scores_gemma":[0.9989692,0.0003760405,0.00020488,0.00005941271,0.00004036761,0.0003502169],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9202097,0.004097286,0.00826049,0.0005951935,0.001088378,0.0001185748,0.00008544834,0.001162563,0.003507572,0.0002198623,0.001142296,0.05951252],"study_design_scores_gemma":[0.697397,0.2670051,0.02681735,0.0001776157,0.001492116,0.0003992669,0.00008471191,0.002354286,0.001320709,0.000639518,0.002280838,0.00003156608],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924946,0.004480431,0.0002009233,0.0003101839,0.0001382866,0.0002656752,0.0003704921,0.00002170396,0.001717693],"genre_scores_gemma":[0.9964592,0.001366066,0.0004164654,0.0004451893,0.0002019372,0.000206578,0.0003955391,0.000003796505,0.0005051909],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003613671,"threshold_uncertainty_score":0.01208895,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4410829664","doi":"10.1007/s40268-025-00511-y","title":"Network Meta-Analysis of Pharmacological Therapies for Long-Term Prophylactic Treatment of Patients with Hereditary Angioedema","year":2025,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"EVERSANA (Canada)","funders":"CSL Behring","keywords":"Hereditary angioedema; Medicine; Prophylactic treatment; Term (time); Intensive care medicine; Angioedema; Meta-analysis; Dermatology; Internal medicine","authors":[{"name":"Sarah N. Walsh","is_ca":true},{"name":"Meaghan Bartlett","is_ca":true},{"name":"Elizabeth M. Salvo‐Halloran","is_ca":true},{"name":"John Sears","is_ca":false},{"name":"Yinglei Li","is_ca":false},{"name":"Maebh Kelly","is_ca":false},{"name":"S. Gavata-Steiger","is_ca":false},{"name":"Chiara Nenci","is_ca":false},{"name":"Iris Jacobs","is_ca":false},{"name":"Ingo Pragst","is_ca":false},{"name":"Neelanjana Ray","is_ca":false},{"name":"Imtiaz A. Samjoo","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0998001851149383,"gpt":0.3768648895175485,"spread":0.2770647044026102,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02629382,0.002774729,0.01306802,0.004773378,0.0005310694,0.002774851,0.002256329,0.002219439,0.004351644],"category_scores_gemma":[0.04331455,0.001232445,0.04968607,0.004497709,0.0004814672,0.001548235,0.00167009,0.002227139,0.0003305335],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002025512,"about_ca_system_score_gemma":0.002226109,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007339313,"about_ca_topic_score_gemma":0.009600856,"domain_scores_codex":[0.9735582,0.01981917,0.002736695,0.001862876,0.001625354,0.000397554],"domain_scores_gemma":[0.9735005,0.02072543,0.002962307,0.001476808,0.0009791689,0.0003558004],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.003424095,0.00001814944,0.00429532,0.02586454,0.9611236,0.00004981261,0.00001721481,0.00122293,0.00008283821,0.000115716,0.0003995318,0.003386235],"study_design_scores_gemma":[0.001364822,0.0001908251,0.003518979,0.001833734,0.990837,0.0000490809,0.00001201659,0.0009689234,0.00006085002,0.0003704717,0.0007774995,0.00001574023],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03103967,0.9555826,0.005787963,0.001150008,0.0008882141,0.0007306936,0.003140825,0.000186865,0.001493295],"genre_scores_gemma":[0.8121486,0.1700946,0.008296615,0.001626297,0.0005320222,0.002389332,0.003946731,0.0001153976,0.000850534],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02629382,"threshold_uncertainty_score":0.1390566,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2530554915","doi":"10.1007/s40268-016-0145-9","title":"Bioequivalence and Pharmacokinetic Evaluation Study of Acetaminophen vs. Acetaminophen Plus Caffeine Tablets in Healthy Mexican Volunteers","year":2016,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Fraser Health","funders":"","keywords":"Bioequivalence; Acetaminophen; Medicine; Pharmacokinetics; Caffeine; Pharmacology; Immediate release; Internal medicine","authors":[{"name":"Nora Guzmán","is_ca":true},{"name":"Daniel Ruiz‐Molina","is_ca":false},{"name":"Benigno Figueroa Núñez","is_ca":false},{"name":"Juan Carlos Soto-Sosa","is_ca":false},{"name":"Jorge Eduardo Herrera Abarca","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1256013498076976,"gpt":0.4379432897756987,"spread":0.3123419399680011,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001441719,0.0005401114,0.0007872945,0.0002038967,0.0003425546,0.0003628696,0.0002585743,0.0006355655,0.001382178],"category_scores_gemma":[0.001768938,0.0002685402,0.0003666306,0.0002243011,0.0005066454,0.0003431724,0.0001863883,0.0004908436,0.0002684463],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002079075,"about_ca_system_score_gemma":0.0003444666,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005023784,"about_ca_topic_score_gemma":0.0004145876,"domain_scores_codex":[0.9992416,0.000386979,0.00005055976,0.0001312256,0.0001504047,0.00003932246],"domain_scores_gemma":[0.9993932,0.0001051479,0.0002625936,0.00006497136,0.00007907101,0.00009493517],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6746179,0.03443659,0.0327939,0.0009793597,0.001770296,0.0002594233,0.0007523344,0.0008963588,0.1744741,0.0002503565,0.000723049,0.07804631],"study_design_scores_gemma":[0.04673364,0.7704797,0.1534027,0.00004100603,0.00164409,0.0005810815,0.0003308344,0.002477883,0.02109845,0.0001026732,0.003051521,0.0000564869],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9985065,0.0004657784,0.0003554323,0.00003485503,0.00002088792,0.0002745184,0.00008182856,0.000009906674,0.0002504978],"genre_scores_gemma":[0.997798,0.0003038403,0.0008431968,0.0001385668,0.00005161545,0.000268393,0.0001358772,0.000005072238,0.0004555124],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001441719,"threshold_uncertainty_score":0.007624626,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3092259600","doi":"10.1007/s40268-020-00323-2","title":"Comparisons of Four Protein-Binding Models Characterizing the Pharmacokinetics of Unbound Phenytoin in Adult Patients Using Non-Linear Mixed-Effects Modeling","year":2020,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital; University of Alberta","funders":"National Research Foundation of Korea","keywords":"Pharmacokinetics; Phenytoin; Pharmacology; Medicine; Chemistry; Epilepsy","authors":[{"name":"Heajin Jun","is_ca":true},{"name":"Yan Rong","is_ca":true},{"name":"Catharina Yih","is_ca":true},{"name":"Jordan Ho","is_ca":true},{"name":"Wendy Cheng","is_ca":true},{"name":"Tony K. L. Kiang","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07519172777881467,"gpt":0.3256941495750178,"spread":0.2505024217962031,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01684397,0.002059893,0.001992966,0.001342333,0.0004846894,0.001389295,0.00257611,0.001397926,0.001879271],"category_scores_gemma":[0.02623851,0.0008250268,0.005617673,0.00060899,0.0005167129,0.0007891802,0.001000644,0.001972351,0.0003283062],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001797456,"about_ca_system_score_gemma":0.002696431,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01575857,"about_ca_topic_score_gemma":0.01080926,"domain_scores_codex":[0.9925187,0.006118042,0.0002291494,0.0006673253,0.0002454186,0.0002213401],"domain_scores_gemma":[0.9717541,0.02594351,0.0009032128,0.0003657434,0.0007775013,0.0002559122],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.004643242,0.0008154375,0.03766977,0.0004842824,0.004092921,0.0002901807,0.0005363647,0.9054894,0.001761228,0.006021278,0.001075326,0.03712053],"study_design_scores_gemma":[0.0001728463,0.0005751587,0.002909694,0.00002971551,0.0005326224,0.0000337326,0.00004642694,0.9931856,0.0003787176,0.001786537,0.0003193548,0.00002959543],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.560361,0.001490619,0.4327507,0.0008887335,0.00009035364,0.0009978092,0.001513853,0.0007344912,0.001172478],"genre_scores_gemma":[0.9110831,0.0004417972,0.08426028,0.0002167111,0.00002832215,0.001399498,0.001347851,0.0001140168,0.001108434],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01684397,"threshold_uncertainty_score":0.08908051,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4399384704","doi":"10.1007/s40268-024-00462-w","title":"Safety and Efficacy of Lemborexant in Insomnia Patients: Results of a Postmarketing Observational Study of Dayvigo® Tablets","year":2024,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Sleep and related disorders","field":"Psychology","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Eisai Canada; Eisai","keywords":"Somnolence; Postmarketing surveillance; Insomnia; Sleep paralysis; Medicine; Observational study; Suicidal ideation; Adverse effect; Sleep disorder; Psychiatry; Internal medicine; Poison control; Emergency medicine; Injury prevention; Excessive daytime sleepiness","authors":[{"name":"Kazuo Mishima","is_ca":false},{"name":"Kenichi Fujimoto","is_ca":false},{"name":"Akira Endo","is_ca":false},{"name":"Mika Ishii","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02254376746278476,"gpt":0.3118689907720825,"spread":0.2893252233092978,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001274326,0.000321626,0.0005944445,0.0004169273,0.0004477969,0.0003852245,0.0002003297,0.0004180084,0.001242756],"category_scores_gemma":[0.003134822,0.0002185903,0.0007687309,0.0003231119,0.0002144778,0.0003922285,0.0002620114,0.000584867,0.0002266091],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002943627,"about_ca_system_score_gemma":0.0003055985,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008472024,"about_ca_topic_score_gemma":0.0008998099,"domain_scores_codex":[0.9993204,0.0001945108,0.00009697158,0.0001058553,0.0002353289,0.0000469816],"domain_scores_gemma":[0.9970574,0.0004693939,0.001699239,0.0001604239,0.0003448561,0.0002687796],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01206194,0.003593443,0.9601305,0.0003103343,0.0004617943,0.0005657435,0.0007420709,0.00009042171,0.006725197,0.00001985248,0.0002385489,0.01506019],"study_design_scores_gemma":[0.0005893426,0.01489477,0.9817523,0.00001629099,0.0002561966,0.0006146721,0.0001900097,0.0003176896,0.0009423601,0.00001107797,0.000396989,0.00001823222],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9993939,0.0002196969,0.00005574922,0.00001276113,0.00000359705,0.00005708108,0.0001139977,0.000003146992,0.0001399317],"genre_scores_gemma":[0.9992071,0.0001370493,0.0001019483,0.00005334727,0.00002205969,0.00004671452,0.0002745361,0.000002085787,0.0001552633],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001274326,"threshold_uncertainty_score":0.006739378,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2749649169","doi":"10.1007/s40268-017-0201-0","title":"Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial","year":2017,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Body Composition Measurement Techniques","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre","funders":"AbbVie","keywords":"Medicine; Placebo; Urology; Internal medicine; Diabetes mellitus; Population; Diabetic nephropathy; Adverse effect; Anesthesia; Endocrinology; Pathology","authors":[{"name":"David J. Webb","is_ca":false},{"name":"Blai Coll","is_ca":false},{"name":"Hiddo J.L. Heerspink","is_ca":false},{"name":"Dennis L. Andress","is_ca":false},{"name":"Yili Pritchett","is_ca":false},{"name":"John J. Brennan","is_ca":false},{"name":"Mark T. Houser","is_ca":false},{"name":"Ricardo Correa‐Rotter","is_ca":false},{"name":"Donald E. Kohan","is_ca":false},{"name":"Hirofumi Makino","is_ca":false},{"name":"Vlado Perkovic","is_ca":false},{"name":"Giuseppe Remuzzi","is_ca":false},{"name":"Sheldon W. Tobe","is_ca":true},{"name":"Robert Toto","is_ca":false},{"name":"Robert S. Busch","is_ca":false},{"name":"Pablo E. Pérgola","is_ca":false},{"name":"Hans‐Henrik Parving","is_ca":false},{"name":"Dick de Zeeuw","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03188235948794835,"gpt":0.3793242938575151,"spread":0.3474419343695667,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002760933,0.001590177,0.004002583,0.0004478372,0.0006839729,0.001093518,0.001040572,0.002536312,0.004158613],"category_scores_gemma":[0.002765821,0.0008314846,0.001988992,0.0004384107,0.001151732,0.0009922439,0.0004161228,0.002673389,0.0005784142],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005869514,"about_ca_system_score_gemma":0.001411652,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009113173,"about_ca_topic_score_gemma":0.001392371,"domain_scores_codex":[0.9988118,0.0006442582,0.0001013166,0.0002200205,0.00008347452,0.0001390545],"domain_scores_gemma":[0.9980339,0.0004713081,0.0005573812,0.0001724303,0.0001862564,0.0005786304],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.990651,0.003685664,0.0003570605,0.0002827029,0.0005105847,0.00001387013,0.00001451651,0.00005950543,0.001008781,0.00001639877,0.000121467,0.00327833],"study_design_scores_gemma":[0.9453526,0.05230523,0.001266991,0.00002393067,0.0004371038,0.00001070576,0.00000843924,0.0001775241,0.0002438904,0.00003306463,0.0001318631,0.000008574934],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9865789,0.006969613,0.0006542795,0.0005192574,0.0007149581,0.002983211,0.0005756628,0.0001259651,0.0008781657],"genre_scores_gemma":[0.9867637,0.003328658,0.001918618,0.0008479655,0.0006947812,0.004518668,0.0005106296,0.00001667232,0.001400418],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004158613,"threshold_uncertainty_score":0.01460135,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2620644176","doi":"10.1007/s40268-017-0186-8","title":"Comparison of Generic Drug Reviews for Marketing Authorization between Japan and Canada","year":2017,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Pharmacy and Medical Practices","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Health Canada","funders":"","keywords":"Marketing authorization; Authorization; Drug; Business; Prior authorization; Medicine; Pharmacology; Computer science; Computer security","authors":[{"name":"Ryosuke Kuribayashi","is_ca":true},{"name":"Scott Appleton","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.259178522825063,"gpt":0.5329395756676412,"spread":0.2737610528425781,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004167489,0.0004137928,0.0006132623,0.01123509,0.001544845,0.003530526,0.000671353,0.0005617646,0.003130929],"category_scores_gemma":[0.02641465,0.0002416059,0.0008476102,0.0175653,0.000700786,0.0009071447,0.0009307235,0.0005130011,0.0002448273],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02941179,"about_ca_system_score_gemma":0.0566381,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8550679,"about_ca_topic_score_gemma":0.93397,"domain_scores_codex":[0.9906261,0.001077658,0.001392449,0.0008606621,0.004894768,0.001148408],"domain_scores_gemma":[0.9348993,0.008070971,0.01306736,0.0006067762,0.03946565,0.003890036],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002347579,0.0001208354,0.6331846,0.01513693,0.001567086,0.00201881,0.009094144,0.000632682,0.003530231,0.005700612,0.06132867,0.2653379],"study_design_scores_gemma":[0.00005169415,0.0001095111,0.9108934,0.001871036,0.0008103549,0.000694107,0.005770911,0.0003273009,0.0009230991,0.0001167698,0.0783582,0.00007347277],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6313743,0.2431916,0.001290506,0.0101741,0.0006642746,0.0008304297,0.02851315,0.0001977436,0.08376388],"genre_scores_gemma":[0.9197019,0.06221117,0.001475384,0.003407099,0.0001639302,0.0001700376,0.006329879,0.00007361228,0.006467023],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1449321,"threshold_uncertainty_score":0.2915712,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2015373259","doi":"10.1007/s40268-014-0057-5","title":"Role of Cognitive Enhancer Therapy in Alzheimer’s Disease with Concomitant Cerebral White Matter Disease: Findings from a Long-Term Naturalistic Study","year":2014,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Hyperintensity; Medicine; Concomitant; Internal medicine; Cognitive decline; Confounding; Montreal Cognitive Assessment; Stroke (engine); Disease; Retrospective cohort study; Cognition; Pediatrics; Magnetic resonance imaging; Psychiatry; Dementia","authors":[{"name":"Kok Pin Ng","is_ca":false},{"name":"Aloysius Ng","is_ca":false},{"name":"Pryseley Nkouibert Assam","is_ca":false},{"name":"Esther Heng","is_ca":false},{"name":"Nagaendran Kandiah","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01276670842920622,"gpt":0.3080751794419951,"spread":0.2953084710127889,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007816928,0.00038734,0.001107882,0.0004348365,0.0008541686,0.0008059469,0.0005499953,0.0008763373,0.0008341073],"category_scores_gemma":[0.013589,0.0002729909,0.001820052,0.0004005574,0.0008453175,0.0008216845,0.0005656632,0.0007026574,0.000177688],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008641502,"about_ca_system_score_gemma":0.001139008,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002877552,"about_ca_topic_score_gemma":0.004064891,"domain_scores_codex":[0.9963462,0.002426379,0.0003786634,0.0003216339,0.0003674061,0.0001598382],"domain_scores_gemma":[0.988353,0.004644716,0.00369331,0.00127989,0.0008941647,0.001135007],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1622858,0.03467425,0.7225999,0.001403331,0.005443268,0.0005864935,0.003256163,0.0003659437,0.002950407,0.0001829438,0.0006754243,0.06557606],"study_design_scores_gemma":[0.007685096,0.118159,0.8679006,0.0002491451,0.001589946,0.0006980859,0.0007926453,0.0009101978,0.0004623691,0.0002292532,0.001243165,0.00008040848],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986107,0.000904784,0.00005843962,0.00005351798,0.0000092145,0.00009091204,0.00006700499,0.000002247559,0.000203058],"genre_scores_gemma":[0.9989182,0.0003185181,0.0002143436,0.0001297278,0.00002780866,0.0001411721,0.0001681619,0.000001321867,0.00008079122],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007816928,"threshold_uncertainty_score":0.04134035,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4232278611","doi":"10.1007/bf03259727","title":"Impact of Intravenous Naltrexone on Intravenous Morphine-Induced High, Drug Liking, and Euphoric Effects in Experienced, Nondependent Male Opioid Users","year":2011,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Celerion (Canada)","funders":"Shionogi; Astellas Pharma; Purdue University; Eisai; Bayer HealthCare; Boston Scientific Corporation; Purdue Pharma; Gilead Sciences; GlaxoSmithKline; Nevro; Teva Pharmaceutical Industries; AstraZeneca; Pfizer","keywords":"Euphoriant; Naltrexone; Morphine; Medicine; Heroin; Anesthesia; Opioid; Narcotic antagonist; Visual analogue scale; Pharmacology; Drug; Internal medicine; Psychiatry","authors":[{"name":"Lynn R. Webster","is_ca":false},{"name":"Franklin K. Johnson","is_ca":false},{"name":"Joseph Stauffer","is_ca":false},{"name":"Beatrice Setnik","is_ca":false},{"name":"Sabrina Ciric","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0124207090589173,"gpt":0.2684139299841857,"spread":0.2559932209252684,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005675518,0.0002894646,0.0004085721,0.0001206218,0.0001421571,0.0002734486,0.00020688,0.0002883402,0.002217887],"category_scores_gemma":[0.001866482,0.0002002657,0.0003916677,0.00008875745,0.0003076595,0.0002700404,0.0001958432,0.0004859602,0.0001570702],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001992926,"about_ca_system_score_gemma":0.0001921216,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003615385,"about_ca_topic_score_gemma":0.0007127988,"domain_scores_codex":[0.9995453,0.0002330897,0.00004546808,0.00004842204,0.00007889125,0.00004874209],"domain_scores_gemma":[0.9991003,0.00035645,0.0002282945,0.00005181682,0.00004014509,0.0002230026],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.504052,0.0952432,0.08338332,0.001102246,0.0009946459,0.0004412752,0.0005294505,0.001302024,0.1914897,0.0001044796,0.0003353839,0.1210222],"study_design_scores_gemma":[0.01699993,0.7160161,0.2496439,0.00003014702,0.0002907943,0.0003580199,0.0001727773,0.001275239,0.01474881,0.00003201501,0.0004043664,0.00002793965],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9997314,0.00005650135,0.00002177912,0.000006296005,0.000003401351,0.00003922874,0.0000242,0.000002399816,0.0001147897],"genre_scores_gemma":[0.9994519,0.00008023233,0.0001498207,0.00003155929,0.00001181372,0.0000450215,0.00005187051,0.000001356931,0.0001763452],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002217887,"threshold_uncertainty_score":0.007419586,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2002722147","doi":"10.2165/00126839-200607010-00003","title":"A Newly Synthesised Molybdenum/Ascorbic Acid Complex Alleviates Some Effects of Cardiomyopathy in Streptozocin-Induced Diabetic Rats","year":2006,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Vanadium and Halogenation Chemistry","field":"Chemistry","cited_by":6,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mount Allison University","funders":"","keywords":"Ascorbic acid; Streptozocin; Internal medicine; Diabetes mellitus; Endocrinology; Diabetic cardiomyopathy; Medicine; Insulin; Chemistry; Streptozotocin; Heart failure; Cardiomyopathy; Food science","authors":[{"name":"K. MacDonald","is_ca":true},{"name":"J. Bailey","is_ca":true},{"name":"C MacRory","is_ca":true},{"name":"Christian Friis","is_ca":true},{"name":"Christopher M. Vogels","is_ca":true},{"name":"Thomas L. Broderick","is_ca":false},{"name":"Stephen A. Westcott","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008430378460796025,"gpt":0.2201597351369941,"spread":0.2117293566761981,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009993841,0.0003177956,0.0003561122,0.0003077281,0.0001781841,0.0002666817,0.0003651482,0.0003565297,0.0008112357],"category_scores_gemma":[0.0001204079,0.0001629999,0.0001582466,0.0001601141,0.00017691,0.0001950912,0.0001745859,0.0004619655,0.0001357813],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001772291,"about_ca_system_score_gemma":0.0002450419,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005235648,"about_ca_topic_score_gemma":0.0006625885,"domain_scores_codex":[0.9999499,0.000007557665,0.000005833242,0.0000143197,0.00001041607,0.00001200264],"domain_scores_gemma":[0.9999392,0.000005855613,0.0000182009,0.000005090721,0.000007604664,0.00002402625],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005440435,0.00004745488,0.0001220196,0.0001270661,0.00002325483,0.00007797231,0.00002601335,0.0001042271,0.9946502,0.0002375773,0.00006767584,0.003972634],"study_design_scores_gemma":[0.00009189799,0.0006460727,0.0005817105,0.000007108362,0.00007403545,0.0001371674,0.000009179466,0.0004039774,0.9942259,0.00007068548,0.003744391,0.000007894103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9838997,0.005801017,0.008376596,0.000132853,0.0001519887,0.00005459195,0.0001628478,0.000208362,0.001212036],"genre_scores_gemma":[0.9926364,0.001341554,0.004405925,0.00004819414,0.00002752873,0.000014838,0.0001424998,0.00001864729,0.001364194],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008112357,"threshold_uncertainty_score":0.002713919,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1990684646","doi":"10.2165/00126839-200506010-00005","title":"Pharmacokinetics and Pilot Efficacy of???a Mesalazine Rectal Gel in Distal Ulcerative Colitis","year":2005,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BioPhage Pharma (Canada); University of Alberta; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Ulcerative colitis; Mesalazine; Medicine; Pharmacokinetics; Gastroenterology; Internal medicine; Pharmacotherapy; Disease","authors":[{"name":"Guy Aumais","is_ca":true},{"name":"Marc Lefebvre","is_ca":true},{"name":"Julie Massicotte","is_ca":true},{"name":"Claude Tremblay","is_ca":true},{"name":"Joelle Kasbo","is_ca":true},{"name":"Jean-S bastien Brunet","is_ca":true},{"name":"Cynthia Cardinal","is_ca":true},{"name":"Michael Grace","is_ca":true},{"name":"Jean Sp nard","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007117704362962512,"gpt":0.2642461372299111,"spread":0.2571284328669486,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008362648,0.0004079856,0.001029481,0.000283109,0.0002284753,0.0007285817,0.0003729661,0.0007286272,0.001400104],"category_scores_gemma":[0.001853491,0.0004309088,0.0006950162,0.0002095022,0.0007109013,0.0008903205,0.000187892,0.001644742,0.0004979854],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004167318,"about_ca_system_score_gemma":0.0003729001,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001024926,"about_ca_topic_score_gemma":0.0006972014,"domain_scores_codex":[0.9993852,0.0003044145,0.00003942207,0.0001006748,0.0000635809,0.0001066296],"domain_scores_gemma":[0.9991905,0.0002918323,0.0001186072,0.0001232257,0.00005324808,0.0002226101],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7241521,0.01610751,0.006935027,0.0001894936,0.0006196692,0.0003601124,0.0002672753,0.002117387,0.1799535,0.0002850878,0.001182141,0.06783067],"study_design_scores_gemma":[0.0575203,0.7041416,0.05715866,0.00002814534,0.00162465,0.001009367,0.0002404126,0.01092348,0.1628293,0.0003282926,0.004057741,0.0001380315],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980509,0.0005667418,0.000410565,0.0001105952,0.00004964126,0.00006986567,0.0001935434,0.00005619248,0.0004918006],"genre_scores_gemma":[0.998643,0.0001735779,0.0003677394,0.00006868895,0.00004787635,0.00003223798,0.0001927761,0.00001910041,0.0004550626],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001400104,"threshold_uncertainty_score":0.004683852,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2079921819","doi":"10.2165/00126839-200607020-00006","title":"Effect of a Novel Molybdenum Ascorbate Complex on Ex Vivo Myocardial Performance in Chemical??Diabetes Mellitus","year":2006,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Vanadium and Halogenation Chemistry","field":"Chemistry","cited_by":4,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mount Allison University","funders":"","keywords":"Diabetes mellitus; Medicine; Internal medicine; Streptozotocin; Endocrinology; Cardiac function curve; Insulin; Heart failure; Cardiology","authors":[{"name":"Tom L. Broderick","is_ca":false},{"name":"John R. Bailey","is_ca":true},{"name":"Karen J Gagnon","is_ca":true},{"name":"Sarah J. Lord","is_ca":true},{"name":"Christopher M. Vogels","is_ca":true},{"name":"Stephen A. Westcott","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007668220954864185,"gpt":0.2299303332794818,"spread":0.2222621123246176,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000404935,0.0003518848,0.0007203975,0.0001324935,0.0002678186,0.0005572208,0.0006577888,0.0007642854,0.002003348],"category_scores_gemma":[0.000443917,0.0002770561,0.0002516094,0.0001991721,0.0003521632,0.0003449331,0.0002682743,0.0006860005,0.0002176785],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002895556,"about_ca_system_score_gemma":0.0003560752,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001157981,"about_ca_topic_score_gemma":0.0008541686,"domain_scores_codex":[0.9998223,0.0000466945,0.00001932083,0.00004069544,0.00001766326,0.00005331276],"domain_scores_gemma":[0.9997852,0.00006890597,0.00003838389,0.00002779996,0.00002286365,0.00005680979],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.02255522,0.0003935341,0.0003598967,0.0001810848,0.0001098425,0.00009971892,0.00007788368,0.000231233,0.9728938,0.0002535856,0.0002116121,0.002632678],"study_design_scores_gemma":[0.0009204746,0.002999276,0.001030644,0.00001211575,0.0001170758,0.000112475,0.00003261608,0.001146681,0.99226,0.00005489141,0.001299722,0.00001385746],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975539,0.0009763933,0.0007677021,0.0001019517,0.00007207772,0.00002685524,0.00008821003,0.00003809162,0.000374861],"genre_scores_gemma":[0.9979971,0.0003946798,0.0006685232,0.0000755192,0.00002176945,0.00001330086,0.0001555176,0.00002131885,0.0006523484],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002003348,"threshold_uncertainty_score":0.006701827,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3200529384","doi":"10.1007/s40268-021-00361-4","title":"The Safety of Agalsidase Alfa Enzyme Replacement Therapy in Canadian Patients with Fabry Disease Following Implementation of a Bioreactor Process","year":2021,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Dalhousie University; University of Toronto; University Health Network; University of British Columbia; Alberta Children's Hospital; Queen Elizabeth II Health Sciences Centre; Université de Montréal; Hôpital du Sacré-Cœur de Montréal; University of Calgary","funders":"Killam Trusts","keywords":"Enzyme replacement therapy; Fabry disease; Medicine; Adverse effect; Internal medicine; Disease","authors":[{"name":"Sandra Sirrs","is_ca":true},{"name":"Daniel G. Bichet","is_ca":true},{"name":"Chantal F. Morel","is_ca":true},{"name":"Adina Tocoian","is_ca":false},{"name":"Lan Lan","is_ca":false},{"name":"Michael L. West","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01011952908031251,"gpt":0.3144048204190735,"spread":0.304285291338761,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001141893,0.0002262026,0.0003705406,0.0001564456,0.0007793255,0.0004389899,0.0003175291,0.0002669514,0.0008230963],"category_scores_gemma":[0.001779325,0.00009094894,0.0002849053,0.000384827,0.0004735276,0.0001509248,0.000196306,0.0004940049,0.00008796826],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007125996,"about_ca_system_score_gemma":0.008147763,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.2190098,"about_ca_topic_score_gemma":0.29108,"domain_scores_codex":[0.9994102,0.0001133852,0.00002745799,0.00006540286,0.0002800232,0.0001036542],"domain_scores_gemma":[0.9988945,0.0001694576,0.0004339957,0.00003831946,0.0002732324,0.000190365],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06756115,0.003357325,0.6652279,0.0009421706,0.0006245662,0.00187908,0.002674695,0.001851603,0.05557214,0.0006787307,0.003525469,0.1961052],"study_design_scores_gemma":[0.003462686,0.05500485,0.9148945,0.0001394731,0.0005405353,0.00248628,0.0009956,0.002435303,0.01053012,0.0001058234,0.009332949,0.00007190051],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978278,0.0008119692,0.0001635856,0.00008649729,0.000005721422,0.00009635575,0.0001264196,0.00000612938,0.000875505],"genre_scores_gemma":[0.99886,0.0003212064,0.0003017055,0.0001019699,0.00000659008,0.00002888724,0.0001758777,0.000001199954,0.0002025852],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7809902,"threshold_uncertainty_score":0.43547,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4402785536","doi":"10.1007/s40268-024-00491-5","title":"Trametinib Sensitivity is Defined by a Myeloid Differentiation Profile in Acute Myeloid Leukemia","year":2024,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Sherbrooke","funders":"National Institute of General Medical Sciences; National Cancer Institute; University of Pennsylvania; U.S. Department of Veterans Affairs","keywords":"Myeloid leukemia; Myeloid; Sensitivity (control systems); Trametinib; Myeloid cells; Medicine; Cancer research; Internal medicine; Biology; Genetics; Engineering; Signal transduction; MAPK/ERK pathway","authors":[{"name":"Mathieu Quesnel-Vallières","is_ca":true},{"name":"D. Schultz","is_ca":false},{"name":"Alena Orlenko","is_ca":false},{"name":"Yancy Lo","is_ca":false},{"name":"Jason H. Moore","is_ca":false},{"name":"Marylyn D. Ritchie","is_ca":false},{"name":"David A. Roth","is_ca":false},{"name":"Martin Carroll","is_ca":false},{"name":"Yoseph Barash","is_ca":false},{"name":"Kristen W. Lynch","is_ca":false},{"name":"Sara Cherry","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0125919187849387,"gpt":0.290093191493942,"spread":0.2775012727090033,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001476552,0.000183182,0.0002372052,0.0006348956,0.0002055461,0.0004162556,0.0001223869,0.0002992104,0.001259368],"category_scores_gemma":[0.0003475778,0.00008970226,0.0001614639,0.0006622659,0.0002104281,0.0001394459,0.0002681446,0.0003222362,0.0003496775],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002433655,"about_ca_system_score_gemma":0.0001243752,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003171074,"about_ca_topic_score_gemma":0.0006970479,"domain_scores_codex":[0.9997438,0.00002698833,0.00003253495,0.00005538765,0.00009617503,0.00004516674],"domain_scores_gemma":[0.9997018,0.00004662013,0.000150195,0.00001504518,0.00004359433,0.00004278091],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001327582,0.00007989209,0.1405576,0.0002079283,0.00006796856,0.000316794,0.0001327157,0.0006746764,0.8383455,0.0001447429,0.0003811509,0.01776333],"study_design_scores_gemma":[0.00002606998,0.0007761896,0.844566,0.00004472171,0.00009959069,0.003359637,0.0002558658,0.0028869,0.1425559,0.0002892093,0.005120145,0.0000197898],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966445,0.001081525,0.0006017772,0.00004606786,0.000005354875,0.00002529767,0.0008685171,0.00002299768,0.0007040358],"genre_scores_gemma":[0.9966768,0.000477586,0.0009987153,0.00007850305,0.000008957387,0.00003216439,0.001401904,0.000005881337,0.0003194613],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001259368,"threshold_uncertainty_score":0.004212976,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3020645024","doi":"10.1007/s40268-020-00307-2","title":"Public Health Outcomes May Differ After Switching from Brand-Name to Generic Angiotensin II Receptor Blockers","year":2020,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Institut Universitaire de Cardiologie et de Pneumologie de Québec; Université Laval; Institut National de Santé Publique du Québec","funders":"Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval; Institut National de Santé Publique du Québec","keywords":"Angiotensin Receptor Blockers; Pharmacology; Brand names; Business; Chemistry; Medicine; Internal medicine; Renin–angiotensin system; Advertising","authors":[{"name":"Jacinthe Leclerc","is_ca":true},{"name":"Claudia Blais","is_ca":true},{"name":"Louis Rochette","is_ca":true},{"name":"Denis Hamel","is_ca":true},{"name":"Line Guénette","is_ca":true},{"name":"Claudia Beaudoin","is_ca":true},{"name":"Paul Poirier","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1037359045488901,"gpt":0.287392709109388,"spread":0.1836568045604979,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00320405,0.0002401723,0.0003043932,0.001371893,0.0004011966,0.001220981,0.0004606234,0.0006224907,0.001573701],"category_scores_gemma":[0.01093179,0.0001870437,0.00101014,0.001756298,0.0004880022,0.0006887807,0.0005381902,0.000826638,0.000251413],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001389511,"about_ca_system_score_gemma":0.001076328,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03073728,"about_ca_topic_score_gemma":0.03025746,"domain_scores_codex":[0.9976076,0.0006033448,0.00017832,0.0004753374,0.0004899161,0.0006455036],"domain_scores_gemma":[0.9893868,0.002016039,0.006195339,0.0007183605,0.001084836,0.0005986192],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001149794,0.00002731278,0.9981269,0.000008523791,0.00008623893,0.00003962262,0.00006882744,0.00005883969,0.00004248472,0.00004154689,0.00009066465,0.001294111],"study_design_scores_gemma":[0.000003315706,0.00003324963,0.9996228,0.000004167836,0.00003215543,0.00003099818,0.00005466854,0.00008248118,0.00002354564,0.0000442575,0.00006611312,0.000002180806],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956416,0.0004214237,0.0002434382,0.0003034721,0.0000170433,0.00002370914,0.001704921,0.000009173394,0.001635093],"genre_scores_gemma":[0.9987301,0.0001174787,0.00007386306,0.00007589492,0.00001528718,0.00001132207,0.0008620164,0.000002693145,0.0001113282],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03073728,"threshold_uncertainty_score":0.06111676,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2160030763","doi":"10.1007/s40268-014-0044-x","title":"Bioequivalence Study of Two Formulations of Ibandronic Acid 150-mg Film-Coated Tablets in Healthy Volunteers Under Fasting Conditions: A Randomized, Open-Label, Three-Way, Reference-Replicated Crossover Study","year":2014,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Bioequivalence; Crossover study; Confidence interval; Pharmacokinetics; Chromatography; Dosing; Bioavailability; Medicine; Chemistry; Pharmacology; Internal medicine","authors":[{"name":"Augusto Filipe","is_ca":false},{"name":"Pedro Pedroso","is_ca":false},{"name":"Susana Almeida","is_ca":false},{"name":"Rita Neves","is_ca":false},{"name":"Sylvie Boudreault","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06410950267279548,"gpt":0.3873579237050685,"spread":0.323248421032273,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003011663,0.001058552,0.002665599,0.0004510571,0.0004486867,0.0007107496,0.0006613457,0.00159371,0.002290623],"category_scores_gemma":[0.002759826,0.0007549069,0.001169105,0.000361412,0.0009910832,0.0007850219,0.0002785826,0.0009356372,0.0005815463],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003900478,"about_ca_system_score_gemma":0.0006907063,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005856834,"about_ca_topic_score_gemma":0.0004914822,"domain_scores_codex":[0.9978326,0.001078957,0.0001643357,0.0004706792,0.0003408444,0.0001125334],"domain_scores_gemma":[0.9988284,0.0002365477,0.0003184809,0.000223698,0.0001773283,0.0002155587],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8332382,0.03166547,0.002654979,0.0009244045,0.001067479,0.00007448085,0.0004269335,0.0005003034,0.102153,0.0001640321,0.0003986766,0.02673205],"study_design_scores_gemma":[0.160218,0.8008214,0.02121304,0.00003526647,0.001041604,0.0001486059,0.0001119281,0.001605305,0.01339817,0.0001172827,0.001205336,0.00008401438],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961378,0.0007666342,0.0009738294,0.00003806632,0.000108778,0.001436216,0.0002256436,0.00004421582,0.0002688187],"genre_scores_gemma":[0.9929161,0.0005162525,0.003345168,0.0001804452,0.0001407968,0.001743188,0.000358041,0.00002016654,0.0007798438],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003011663,"threshold_uncertainty_score":0.01592737,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2900862674","doi":"10.1007/s40268-018-0255-7","title":"Post Hoc Analysis of the CONFIDENCE II, PROTECT I, SHAKE THE HABIT I and SHAKE THE HABIT II Observational Studies in Mild to Moderate Hypertensive Patients Treated with Perindopril and Atorvastatin Concomitantly","year":2018,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"McGill University","funders":"Institut de Recherches Servier","keywords":"Shake; Perindopril; Medicine; Post-hoc analysis; Observational study; Internal medicine; Post hoc; Cardiology; Engineering; Blood pressure","authors":[{"name":"John S. Sampalis","is_ca":true},{"name":"Eliofotisti Psaradellis","is_ca":false},{"name":"Melissa Stutz","is_ca":false},{"name":"Jenaya Rickard","is_ca":false},{"name":"Emmanouil Rampakakis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06154146838293655,"gpt":0.2998606053313985,"spread":0.238319136948462,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0255628,0.001177887,0.003023113,0.001229246,0.0004954857,0.0009331894,0.001137391,0.0008742302,0.002562902],"category_scores_gemma":[0.02797464,0.0004764621,0.009175481,0.001027892,0.0007595801,0.000595514,0.0009462076,0.001388929,0.0001107382],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007881423,"about_ca_system_score_gemma":0.001896986,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004235443,"about_ca_topic_score_gemma":0.006358929,"domain_scores_codex":[0.9707718,0.02046823,0.002088719,0.002745132,0.002362571,0.001563558],"domain_scores_gemma":[0.9477759,0.03626173,0.00686817,0.005054813,0.002512613,0.001526807],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4216124,0.001270139,0.4161331,0.001969388,0.1337231,0.0005471621,0.0008196383,0.001808221,0.005169162,0.0004789359,0.002338882,0.01412994],"study_design_scores_gemma":[0.01930745,0.07842082,0.811554,0.0001488315,0.07117096,0.0004089614,0.0006764987,0.009663298,0.003084376,0.0004410215,0.005006704,0.0001170122],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914204,0.002028212,0.002946222,0.0001026939,0.0002137564,0.0008504018,0.001731585,0.00004522072,0.0006614957],"genre_scores_gemma":[0.9938069,0.0002035207,0.00275722,0.0001319986,0.00009452784,0.0009611227,0.001278567,0.00002652349,0.0007395123],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0255628,"threshold_uncertainty_score":0.1351906,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2083411973","doi":"10.2165/00126839-200607020-00005","title":"Gut Transport of a Molybdenum/Ascorbic Acid Complex","year":2006,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Chromium effects and bioremediation","field":"Environmental Science","cited_by":2,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mount Allison University","funders":"","keywords":"Molybdenum; Ascorbic acid; Small intestine; Incubation; Biochemistry; Chemistry; Biophysics; Biology; Inorganic chemistry; Food science","authors":[{"name":"M S Russell","is_ca":true},{"name":"J. Bailey","is_ca":true},{"name":"StephenJ Duffy","is_ca":true},{"name":"Christopher M. Vogels","is_ca":true},{"name":"Tom L. Broderick","is_ca":false},{"name":"Stephen A. Westcott","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.00581913416401765,"gpt":0.2082372168515531,"spread":0.2024180826875355,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002662909,0.0002972381,0.0003760414,0.0002024282,0.0002905697,0.001021709,0.0003124916,0.0006630819,0.002180772],"category_scores_gemma":[0.0003163464,0.0002112294,0.0003481021,0.0001367771,0.0003318229,0.0004172899,0.0002953474,0.0007957447,0.0003745629],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00108255,"about_ca_system_score_gemma":0.0006244837,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002759039,"about_ca_topic_score_gemma":0.002440974,"domain_scores_codex":[0.9998304,0.00002871799,0.000005270863,0.0000516209,0.0000188214,0.00006520752],"domain_scores_gemma":[0.9998429,0.00003855509,0.00003419442,0.00001773611,0.00001949728,0.00004705277],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002579458,0.00004960278,0.0003754754,0.000134484,0.00003113722,0.0001314084,0.0001052304,0.0001357657,0.9898136,0.0008655074,0.000241583,0.005536704],"study_design_scores_gemma":[0.0002281485,0.001794819,0.002245237,0.00002561775,0.0001151692,0.0003503647,0.0001562444,0.003567364,0.9848105,0.0001403205,0.006546077,0.00002015556],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927106,0.002378469,0.002418941,0.0003007634,0.0001315544,0.00002995344,0.0001477727,0.00008979927,0.001792108],"genre_scores_gemma":[0.9918327,0.00053829,0.002290827,0.00005179916,0.00003256571,0.000007715178,0.0001462364,0.00002833059,0.005071498],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002759039,"threshold_uncertainty_score":0.007854521,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4211130856","doi":"10.2165/11586020-000000000-00000","title":"Telaprevir","year":2010,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Hepatitis C virus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Telaprevir; Ribavirin; Medicine; Pegylated interferon; Pharmacology; Protease inhibitor (pharmacology); Hepatitis C virus; Clinical trial; Virology; Combination therapy; Internal medicine; Virus; Viral load","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.0885571778742468,"gpt":0.4554097498599943,"spread":0.3668525719857475,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001643803,0.0004924763,0.0006879892,0.0008025297,0.000172175,0.0005341394,0.0005145608,0.0005495722,0.0142287],"category_scores_gemma":[0.0002531701,0.0001290536,0.0003794038,0.0005838068,0.0001245222,0.0004344288,0.0003049169,0.0009758617,0.009328521],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002623404,"about_ca_system_score_gemma":0.0003322094,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005629712,"about_ca_topic_score_gemma":0.001200742,"domain_scores_codex":[0.9998939,0.00001984346,0.00001186232,0.00002219211,0.00003923834,0.00001292295],"domain_scores_gemma":[0.9999495,0.00001464274,0.00001137164,0.000002267214,0.00001233943,0.000009962877],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002190426,0.00009567026,0.00008930325,0.005034596,0.00005690928,0.0002304641,0.00002352506,0.0001045032,0.003032466,0.001053374,0.03243914,0.9576212],"study_design_scores_gemma":[0.0002059744,0.0002653702,0.0008435354,0.001286412,0.00009026503,0.003000193,0.00002789874,0.00006863393,0.002016137,0.0006272654,0.9915558,0.00001256445],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001352094,0.9730156,0.0005138688,0.0006217748,0.0004746775,0.00007017008,0.0002771424,0.00007561479,0.02359906],"genre_scores_gemma":[0.01377471,0.9597685,0.0009835885,0.001431219,0.0003613306,0.00008927998,0.0007073791,0.00001022808,0.02287377],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0142287,"threshold_uncertainty_score":0,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2579057398","doi":"10.1007/s40268-017-0173-0","title":"A Review of Clinical Outcomes Associated with Two Meropenem Dosing Strategies","year":2017,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Meropenem; Dosing; Medicine; Intensive care medicine; Regimen; MEDLINE; Carbapenem; Neutropenia; Internal medicine; Antibiotics; Chemotherapy","authors":[{"name":"Kyle John Wilby","is_ca":false},{"name":"Ziad G. Nasr","is_ca":false},{"name":"Shereen Elazzazy","is_ca":false},{"name":"Tim T Y Lau","is_ca":true},{"name":"Anas Hamad","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2368206627269194,"gpt":0.5424964920427081,"spread":0.3056758293157887,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001925258,0.00115255,0.003522829,0.007865193,0.0004114933,0.00147887,0.001440599,0.001085952,0.003245322],"category_scores_gemma":[0.006629308,0.0005496382,0.00278397,0.008710836,0.000535351,0.001504656,0.0007750161,0.0008138674,0.000395307],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001506968,"about_ca_system_score_gemma":0.003715609,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002752945,"about_ca_topic_score_gemma":0.004719402,"domain_scores_codex":[0.9980248,0.0004056729,0.000902599,0.000189527,0.0004073562,0.00006994604],"domain_scores_gemma":[0.995562,0.003039991,0.0007755151,0.00005998262,0.0004890061,0.00007369487],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0002525024,0.0000639154,0.0005685318,0.5868801,0.001481621,0.0002344058,0.0002133222,0.000204662,0.0005113989,0.0006666436,0.00762691,0.401296],"study_design_scores_gemma":[0.0002099887,0.0008502761,0.01137348,0.6088481,0.02000808,0.004977246,0.0006660164,0.0001976185,0.0009800142,0.001051383,0.3507286,0.0001091494],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001871683,0.9994714,0.00002385881,0.00005713626,0.00003974412,0.00001333804,0.00003542634,0.000002115205,0.0001699294],"genre_scores_gemma":[0.001011452,0.9986768,0.000101404,0.00007836162,0.00003176629,0.00001872221,0.0000360178,7.890341e-7,0.00004464135],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007865193,"threshold_uncertainty_score":0.01093388,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4396608809","doi":"10.1007/s40268-024-00459-5","title":"Retrospective Assessment of Translational Pharmacokinetic–Pharmacodynamic Modeling Performance: A Case Study with Apitolisib, a Dual PI3K/mTOR Inhibitor","year":2024,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway; Pharmacodynamics; Pharmacokinetics; Dual (grammatical number); Pharmacology; Medicine; Chemistry; Biochemistry; Signal transduction; Philosophy","authors":[{"name":"Anita Moein","is_ca":true},{"name":"Jin Y. Jin","is_ca":false},{"name":"Matthew Wright","is_ca":false},{"name":"Bruno Alicke","is_ca":false},{"name":"Harvey Wong","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01153475692529791,"gpt":0.3250791939346348,"spread":0.3135444370093369,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002682603,0.0006326875,0.0005366837,0.0005607172,0.0003531264,0.001107112,0.000640882,0.0009374138,0.001086873],"category_scores_gemma":[0.005299997,0.0002580637,0.0007156882,0.0004325828,0.0003736716,0.000534057,0.0004656095,0.0008196633,0.0003551781],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007408483,"about_ca_system_score_gemma":0.0006329951,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005313326,"about_ca_topic_score_gemma":0.003097465,"domain_scores_codex":[0.9993106,0.0002557554,0.00004603959,0.0001643463,0.0001774378,0.00004586727],"domain_scores_gemma":[0.996396,0.00209796,0.0003919117,0.0004840544,0.0005215406,0.0001085263],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.003704945,0.002648381,0.2267114,0.0003974634,0.0005830974,0.007704314,0.001001696,0.6055652,0.04918518,0.002383476,0.004526486,0.0955884],"study_design_scores_gemma":[0.0001008121,0.002782564,0.04027655,0.0000269005,0.0002001008,0.003104741,0.0003880344,0.9113281,0.03663789,0.0008219711,0.004236236,0.00009608024],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9763353,0.0002919767,0.02046632,0.000198838,0.00001712299,0.0001291935,0.0005694738,0.0002586859,0.001732981],"genre_scores_gemma":[0.9928236,0.0001627158,0.006085857,0.00002799055,0.000006883152,0.00004330744,0.0003436324,0.00004778834,0.000458293],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9973174,"threshold_uncertainty_score":0.0141871,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4312064980","doi":"10.1007/s40268-022-00410-6","title":"A Randomised Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of Palovarotene Ophthalmic Solution","year":2022,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Altasciences (Canada)","funders":"Ipsen","keywords":"Tolerability; Medicine; Pharmacokinetics; Adverse effect; Placebo; Internal medicine; Anesthesia","authors":[{"name":"William J. Foster","is_ca":true},{"name":"Andrew Strahs","is_ca":false},{"name":"Kent W. Small","is_ca":false},{"name":"James Roach","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03184393169426662,"gpt":0.3427165005340247,"spread":0.3108725688397581,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002961912,0.001406871,0.002856658,0.0004294272,0.0004451253,0.001007485,0.001004323,0.00160953,0.01260067],"category_scores_gemma":[0.002994615,0.0009102551,0.001132416,0.0004882244,0.001284292,0.001103892,0.0004361319,0.001989285,0.001600865],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007353728,"about_ca_system_score_gemma":0.002380225,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004462856,"about_ca_topic_score_gemma":0.001126203,"domain_scores_codex":[0.9987969,0.0006075015,0.00008464738,0.0002369844,0.0001284673,0.0001454765],"domain_scores_gemma":[0.9980313,0.0004814218,0.0005733728,0.0002141096,0.0001925146,0.0005073029],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9570636,0.01831567,0.0006119755,0.0007366334,0.0004550267,0.00006397129,0.0000666205,0.0002294339,0.009407289,0.0001716816,0.0008341134,0.01204408],"study_design_scores_gemma":[0.7990611,0.1976726,0.0008999429,0.00003340773,0.0001831509,0.00004314616,0.00002042269,0.0001932018,0.0004873023,0.0001334385,0.001261005,0.00001127357],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9359109,0.004524433,0.003622415,0.0008154596,0.001320275,0.04733936,0.002973693,0.0002130575,0.003280387],"genre_scores_gemma":[0.9339051,0.003465626,0.007626011,0.001964744,0.0007967277,0.04137836,0.001889045,0.00005660763,0.008917917],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01260067,"threshold_uncertainty_score":0.04215342,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4404524533","doi":"10.1007/s40268-024-00496-0","title":"In-Use Physicochemical Stability of Sandoz Rituximab Biosimilar in 0.9% Sodium Chloride Solution After Prolonged Storage at Room Temperature Conditions","year":2024,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Sandoz Canada","keywords":"Relative humidity; Chemistry; Chromatography; Shelf life; Sodium; Humidity; Sodium dodecyl sulfate; Food science; Organic chemistry","authors":[{"name":"Roman Borišek","is_ca":false},{"name":"André Mischo","is_ca":false},{"name":"Tobias Foierl","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01396920320488404,"gpt":0.2779864494744776,"spread":0.2640172462695936,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005629698,0.0002913401,0.0002259769,0.0001767243,0.0002110617,0.0004115057,0.000313789,0.0003811674,0.001564786],"category_scores_gemma":[0.0009505941,0.000113475,0.0002796593,0.0001938971,0.0002233665,0.0002844651,0.0002404319,0.0003332171,0.0004342435],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003348792,"about_ca_system_score_gemma":0.0003009665,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009494658,"about_ca_topic_score_gemma":0.001102711,"domain_scores_codex":[0.9994189,0.0001202076,0.00004748553,0.0001084675,0.000256491,0.00004841453],"domain_scores_gemma":[0.9995415,0.00007100638,0.0001520561,0.00004627043,0.0001551025,0.00003401809],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003594969,0.00004195982,0.001547009,0.00006879032,0.00002439646,0.00008779975,0.0001097829,0.0001816363,0.9943175,0.0000358612,0.0001150558,0.003110746],"study_design_scores_gemma":[0.00001382111,0.001164916,0.01078239,0.00001761233,0.00007073755,0.0003850809,0.0001062521,0.0008024996,0.9838468,0.00004181894,0.002742643,0.00002542734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949227,0.001419104,0.002171835,0.00005563817,0.00002974714,0.00003798991,0.0003101115,0.00003808346,0.001014759],"genre_scores_gemma":[0.9954389,0.0006130562,0.001741721,0.00004164639,0.00001381507,0.000037231,0.0005192035,0.00002018618,0.00157439],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001564786,"threshold_uncertainty_score":0.005234659,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W27770296","doi":"10.1007/s40268-016-0139-7","title":"Types of Support Accessed by Families of Young Children with Disabilities Living in Alberta.","year":2004,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Family and Disability Support Research","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Psychology; Sample (material); Family income; Gerontology; Developmental psychology; Medicine; Economic growth","authors":[{"name":"Jane Drummond","is_ca":false},{"name":"Linda McDonald","is_ca":false},{"name":"Sandra MacKenzie-Keating","is_ca":false},{"name":"Darcy Fleming","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01601996718566453,"gpt":0.3137259607633713,"spread":0.2977059935777068,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032481,0.0003001768,0.0002723633,0.0006765227,0.002937569,0.0008056425,0.0009512954,0.0005493433,0.2213711],"category_scores_gemma":[0.002644759,0.0001155602,0.0003562623,0.001677917,0.0002136839,0.0006688993,0.00181732,0.0004951804,0.01926595],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002448266,"about_ca_system_score_gemma":0.008517329,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.2209358,"about_ca_topic_score_gemma":0.3834787,"domain_scores_codex":[0.9996474,0.00004991817,0.00002074746,0.00003375909,0.00009064315,0.0001574982],"domain_scores_gemma":[0.9986485,0.0001613997,0.0001437271,0.00004426634,0.0002895281,0.000712656],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.0001803668,0.0001773779,0.06707769,0.0009729389,0.0000370061,0.003473346,0.004112468,0.00008447321,0.0002578506,0.001712079,0.5577592,0.3641552],"study_design_scores_gemma":[0.00008107816,0.0001064759,0.1720841,0.001582077,0.00004765717,0.002828507,0.01854233,0.00007897846,0.0001521813,0.0008472833,0.8036157,0.00003370246],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.1900958,0.01128801,0.0005327964,0.01305727,0.001843417,0.0006278805,0.05983374,0.0005086278,0.7222124],"genre_scores_gemma":[0.4712494,0.02045878,0.003126154,0.007893126,0.0005877761,0.001221086,0.02721367,0.0001989913,0.468051],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.7790642,"threshold_uncertainty_score":0.7405601,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4249646940","doi":"10.1007/bf03262369","title":"Food Effects on the Pharmacokinetics of Doxylamine Hydrogen Succinate 25 mg Film-Coated Tablets","year":2012,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Poisoning and overdose treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Pharmacokinetics; Pharmacology; Bioavailability; Antihistamine; Crossover study; Medicine; Chemistry; Placebo","authors":[{"name":"Sebastián Videla","is_ca":false},{"name":"Mounia Lahjou","is_ca":true},{"name":"Pascal Guibord","is_ca":true},{"name":"Zhengguo Xu","is_ca":false},{"name":"Carles Tolrà","is_ca":false},{"name":"Gregorio Encina","is_ca":false},{"name":"Éric Sicard","is_ca":true},{"name":"Artur Sans","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01396631661582227,"gpt":0.2747078549690658,"spread":0.2607415383532435,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004856048,0.0003548431,0.0006207299,0.0002052948,0.0001482982,0.0003179374,0.0002126579,0.0003585284,0.001111831],"category_scores_gemma":[0.001088257,0.00033171,0.0003962223,0.0001848658,0.0003422982,0.0002988438,0.0001211105,0.0005586357,0.0002351869],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002292106,"about_ca_system_score_gemma":0.0003688687,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005505864,"about_ca_topic_score_gemma":0.0007432399,"domain_scores_codex":[0.999649,0.0001536286,0.00002617602,0.00006585899,0.00006421677,0.00004096999],"domain_scores_gemma":[0.9995147,0.0001665391,0.0001544239,0.000052357,0.00004038704,0.00007162847],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.220306,0.005815832,0.004864735,0.0003829287,0.0003615693,0.0003148596,0.0002565557,0.000685157,0.6994866,0.0001213679,0.0005764405,0.0668281],"study_design_scores_gemma":[0.0174565,0.5195122,0.1481422,0.00005952783,0.0008879018,0.0008471902,0.0002488702,0.007679077,0.2986221,0.0001324029,0.006311088,0.0001009033],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980982,0.0008233653,0.0004047424,0.00002849662,0.0000260596,0.0001122216,0.0001355378,0.0000301634,0.0003412963],"genre_scores_gemma":[0.9968385,0.0007338608,0.001001221,0.00007733368,0.00003416445,0.00009647306,0.0002843169,0.00001392962,0.0009202078],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001111831,"threshold_uncertainty_score":0.003719449,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4411554374","doi":"10.1007/s40268-025-00514-9","title":"Demonstrating Bioequivalence for a Lumacaftor Monosubstance Formulation Versus Orkambi® (Lumacaftor/Ivacaftor) in Healthy Subjects","year":2025,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ted Rogers Centre for Heart Research; Heart and Stroke Foundation; Micropharma (Canada); University of Toronto","funders":"","keywords":"Ivacaftor; Bioequivalence; Medicine; Pharmacology; Pharmacokinetics; Internal medicine","authors":[{"name":"Alexandra Papaelias","is_ca":true},{"name":"Darcy Lidington","is_ca":true},{"name":"Steffen‐Sebastian Bolz","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03127630825639068,"gpt":0.3832231826700569,"spread":0.3519468744136663,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004402917,0.0004264094,0.0006350266,0.0002466191,0.0003123483,0.0005504314,0.0003478192,0.001000038,0.004319775],"category_scores_gemma":[0.002731373,0.0002168176,0.0004976777,0.0002287931,0.0005074904,0.000378899,0.0001925028,0.0006153352,0.0006764102],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002975761,"about_ca_system_score_gemma":0.0003986776,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004811213,"about_ca_topic_score_gemma":0.0004881849,"domain_scores_codex":[0.9983298,0.0009406641,0.000111438,0.0003046175,0.0002211324,0.00009238799],"domain_scores_gemma":[0.9988846,0.0003157461,0.0003962853,0.0001374248,0.000120434,0.0001455479],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.664363,0.01602438,0.01482137,0.0009915286,0.001128023,0.0002277213,0.0007175023,0.0005374285,0.2042293,0.0004639228,0.002597877,0.09389793],"study_design_scores_gemma":[0.05583523,0.6913999,0.1775208,0.0001422709,0.001705967,0.0009956565,0.0003564837,0.003719273,0.06088364,0.0002806621,0.007071577,0.00008854749],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952651,0.0009278646,0.001174973,0.00007816245,0.0000844052,0.0008559121,0.0005738286,0.00004834149,0.0009913804],"genre_scores_gemma":[0.9961152,0.0002807265,0.00146267,0.0001255457,0.0000639789,0.0004469345,0.0004486538,0.00001484696,0.001041441],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004402917,"threshold_uncertainty_score":0.02328515,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4411698938","doi":"10.1007/s40268-025-00515-8","title":"In-Vitro Comparison of Physical Characteristics, Enzyme Content, and Release Kinetics of Pancreatic Enzyme Preparations Available in Europe and Canada","year":2025,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Pancreatitis Pathology and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Pancreatic enzymes; Enzyme; Enzyme kinetics; Kinetics; In vitro; Chemistry; Biochemistry; Food science; Physics","authors":[{"name":"Sven Hartmann","is_ca":false},{"name":"Jonas Rosendahl","is_ca":false},{"name":"Amy Todd","is_ca":false},{"name":"Emma Bennett-Huntley","is_ca":false},{"name":"J. Enrique Domínguez‐Muñoz","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01639224360986564,"gpt":0.2781121794221753,"spread":0.2617199358123096,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009921815,0.0003083845,0.0003303382,0.000825236,0.0004873052,0.0007991212,0.0003454379,0.000290711,0.001242917],"category_scores_gemma":[0.001316597,0.0001608931,0.0004257705,0.001261569,0.000429752,0.0002166543,0.0003583005,0.0003089899,0.0002085394],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003094812,"about_ca_system_score_gemma":0.003213119,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.3662506,"about_ca_topic_score_gemma":0.3623105,"domain_scores_codex":[0.9983888,0.000166981,0.0001523884,0.0002348973,0.0008764429,0.0001805694],"domain_scores_gemma":[0.9989937,0.0001583402,0.0001803629,0.0000520629,0.00054714,0.0000684444],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.006080269,0.0005910645,0.07052725,0.001378745,0.0005410836,0.001033093,0.001170404,0.002353955,0.8508063,0.0006398319,0.001513067,0.06336502],"study_design_scores_gemma":[0.0001341864,0.004097804,0.3569508,0.0002550488,0.0007253276,0.001347144,0.001333692,0.003201738,0.6039842,0.00009889372,0.02776503,0.0001059914],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98512,0.006369417,0.001195032,0.00006400785,0.00002198213,0.00009073601,0.001709534,0.00002007622,0.005409258],"genre_scores_gemma":[0.9849831,0.004261413,0.003467992,0.0001138426,0.000009727441,0.00005010901,0.002814176,0.00003240734,0.004267083],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6337494,"threshold_uncertainty_score":0.7282376,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}